Page last updated: 2024-08-21

vancomycin and Clostridioides difficile Infection

vancomycin has been researched along with Clostridioides difficile Infection in 578 studies

Research

Studies (578)

Timeframe	Studies, this research(%)	All Research%
pre-1990	96 (16.61)	18.7374
1990's	17 (2.94)	18.2507
2000's	38 (6.57)	29.6817
2010's	301 (52.08)	24.3611
2020's	126 (21.80)	2.80

Authors

Authors	Studies
Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M	1
Byrne, B; Emery, J; Krulicki, W; Louie, TJ; Mah, M	1
Donskey, C; Goldstein, EJ; Louie, T; Miller, M; Mullane, K	1
Brewer, J; Dean, K; Ding, J; Dzink-Fox, J; Gamber, G; Jain, A; Kerrigan, R; Krastel, P; LaMarche, MJ; Lee, K; Leeds, JA; Lombardo, F; McKenney, D; Neckermann, G; Osborne, C; Palestrant, D; Patane, MA; Rann, EM; Robinson, Z; Schmitt, E; Stams, T; Tiamfook, S; Whitehead, L; Yu, D	1
Anne Marie, V; Cai, J; Li, C; Li, Y; Nimmagadda, A; Peng, Z; Su, M; Sun, X; Teng, P	1
Cole, AG; Hilbert, DW; Letourneau, JJ; Li, Y; Ma, L; Marinelli, BA; Pechik, I; Quintero, JG; Sabalski, J; Stein, PD; Stroke, IL; Sturzenbecker, LJ; Webb, ML	1
Hammer, KA; Hutton, ML; Keller, PA; Knight, DR; Lyras, D; Putsathit, P; Pyne, SG; Riley, TV; Tague, AJ; Wales, SM	1
Brown, N; Silverman, MH; Wright, G; Xu, WC; Yu, XY	1
Blake, S; Hixon, MS; Janda, KD; Lin, M; Rivera, AJ; Thanissery, R; Theriot, CM	1
Alangaden, GJ; Church, B; Davis, SL; Kenney, RM; Wu, T	1
Chiu, CW; Hung, YP; Ko, WC; Lee, CC; Lee, JC; Tsai, PJ	1
Allerberger, F; Bouza, E; Burns, K; Coia, JE; Fitzpatrick, F; Goorhuis, A; Guery, B; Hristea, A; Krutova, M; Kuijper, EJ; Norén, T; Ooijevaar, RE; Reigadas, E; Scharvik Olesen, BR; Tschudin-Sutter, S; van Prehn, J; van Rossen, TM; Vehreschild, MJGT; Vogelzang, EH; Wilcox, MH	1
Dong, K; Fang, N; Ha, D; Holubar, M; Lee, S; Leung, T; Meng, L	1
Jeong, JS; Lee, M; Park, H	1
Altemeier, OJ; Konrardy, KT	1
Arias, CA; Brown, EL; Darkoh, C; DuPont, HL; Hanson, BM; Keita, K; Odo, C; Oyaro, M	1
Benin, AL; Edwards, JR; Leaptrot, D; Li, Q; O'Leary, EN; Wu, H; Xu, K	1
Collins, DA; Riley, TV	1
Carlson, TJ; Garey, KW; Gonzales-Luna, AJ	1
Bazazhina, A; Najjar-Debbiny, R; Saliba, W; Schwartz, N; Shaked, P; Weber, G	1
de Meij, TGJ; Drew, RJ; Fitzpatrick, F; Krutova, M; Kuijper, EJ; Wilcox, MH	1
Meng, L; Yang, H; Yang, J	1
Calais, LA; Climo, MW; Donskey, CJ; Ge, L; Gerding, DN; Goetz, MB; Goldberg, AM; Gordin, FM; Gupta, K; Haegerich, T; Johnson, M; Johnson, N; Johnson, S; Li, X; Reda, DJ; Ringer, R	1
Armiñanzas Castillo, C; Cano Yuste, A; Cobo Reinoso, J; De La Torre Cisneros, J; Díaz Pollán, B; Escudero-Sanchez, R; Fernández Fradejas, J; García Basas, L; García Fernández, S; Giner, L; Gutierrez Rojas, A; Gutiérrez, B; López Medrano, F; Martín Segarra, O; Merino De Lucas, E; Muriel García, A; Olmedo Sampedrio, M; Ramos Martínez, A; Rodríguez Hernández, MJ; Rodríguez-Pardo, D; Ruíz Ruigomez, M; Sáez Bejar, C; Salavert Lletí, M; Tasias Pitarch, M; Valencia Alijo, A	1
Allerberger, F; Barf, LM; Burgener, IA; Cabal, A; Ehricht, R; Feßler, AT; Finsterwalder, SK; Künzel, F; Loncaric, I; Marz, M; Monecke, S; Ruppitsch, W; Schwarz, S; Spergser, J; Szostak, MP; Tichy, A	1
Adu, KT; Apidianakis, Y; Athamneh, AIM; Biazzo, M; de la Fuente-Nunez, C; Deshpande, R; Martens, MG; Muthuirulan, P; Pal, R; Pawar, S; Ramirez, JAR; Seleem, MN; Sundekilde, UK; Tegos, GP	1
Fitzpatrick, F; Safdar, N; Tschudin-Sutter, S; van Prehn, J	1
Donskey, CJ; Greentree, DH; Rice, LB	1
Aftandilian, CC; Agyeman, PKA; Castagnola, E; Chirra, KM; Dupuis, LL; Groll, AH; Haeusler, GM; Lehrnbecher, T; Loves, R; Phillips, B; Schneider, C; Sung, L; van de Wetering, M	1
Chae, GB; Cho, H; Choi, DH; Kang, CD; Lee, KY; Lee, SH; Lee, SJ; Nam, SJ; Park, HK; Park, JM; Park, SC	1
Gargis, AS; Halpin, AL; Lutgring, JD; McDonald, LC; McKay, SL	1
Alam, MJ; Begum, K; Garey, KW; Gonzales-Luna, AJ; Hu, C; Lancaster, C; Loveall, C; McPherson, J; Silverman, MH; Wang, W	1
Budi, ND; Godfrey, JJ; Rose, WE; Safdar, N; Shukla, SK	1
Enoki, Y; Hasegawa, T; Kunishima, H; Matsumoto, K; Mihara, T; Mikamo, H; Mori, N; Morinaga, Y; Nakamura, A; Ohge, H; Sasaki, M; Shimamura, C; Shimamura, R; Suzuki, H; Suzuki, S; Taguchi, K; Tashiro, S; Yamagishi, Y; Yanagihara, K; Yoshikawa, M; Yoshizawa, S	1
Dai, J; Gong, J; Guo, R	1
Chen, Y; Gu, S; Li, L; Lv, L; Quan, J; Wu, Z; Xu, Q; Zhang, S; Zheng, B	1
Bidell, MR; Molleti, RR; Tatara, AW	1
Andreasen, SE; Baunwall, SMD; Dahlerup, JF; Damsgaard, EMS; Eriksen, LL; Erikstrup, C; Hansen, MM; Hvas, CL; Høyer, KL; Kelsen, J; Mikkelsen, S; Rågård, N; Rubak, T; Støy, S	1
Gottlieb, M; Long, B	1
Adamczyk, M; Albrecht, V; Anderson, KF; Campbell, D; Elkins, CA; Gargis, AS; Guh, AY; Halpin, AL; Karlsson, M; Kent, AG; Korhonen, LC; Lutgring, JD; McAllister, G; McDonald, LC; McKay, SL; Paulick, AL; Rasheed, JK; Vlachos, N	1
Appaneal, HJ; LaPlante, KL; Liao, JX; Vicent, ML; Vyas, A	1
Chuard, C; Meuwly, M	1
Beam, E; Miller, VL; Sampathkumar, P; Yetmar, ZA	1
Bishop, EJ; Tiruvoipati, R	1
Cascio, A; Gizzi, A; Granata, G; Iaria, C; Imburgia, C; Pipitone, G; Sartelli, M	1
Delbalso, AN; Hitchcock, AM; Kufel, WD; Paolino, KM	1
Allegretti, J; Chang, LL; Dubberke, ER; Skinner, AM	1
Beneš, J; Kohout, P; Krůtová, M; Musil, V; Stebel, R; Vejmelka, J	1
Araújo, OR; Barbosa, LC; Carlesse, FAMC; Carreira, LY; Fonseca, FMCD; Lima, APC; Marques, LMA; Pignati, LT; Silva, AMPSD; Silva, DCBD; Sodré, JJM	1
Enoki, Y; Matsumoto, K; Mihara, T; Okawa, R; Samura, M; Taguchi, K; Tanaka, Y; Tashiro, S; Yamagishi, Y	1
Bartel, J; Bernecker, S; Brauer, M; Bublitz, A; Deschner, F; Fuchs, TM; Herrmann, J; Hofer, W; Jansen, R; Kany, AM; Lesker, TR; Müller, R; Müsken, M; Neumann-Schaal, M; Nübel, U; Paul, LS; Riedel, K; Sievers, S; Strowig, T; Wagner, S; Zühlke, D	1
Jung, L; Lübbert, C; Schönherr, S	1
Farraye, FA; Hashash, JG; Khanna, S; Koop, AH; Pardi, DS; Travers, PM	1
Brizendine, KD; Budev, M; Fitzmaurice, MG; Hohlfelder, B; Rudoni, M; Srinivas, P	1
Moonah, S; Shirley, DA; Tornel, W; Warren, CA	1
Aguado, JM; Callejas-Diaz, A; Campion, K; Candela, G; Diaz-Pollan, B; Fernández-Ruiz, M; Ferrari, JM; Garcia, MT; Llorente Muñoz, I; Lora, D; Martinez-Uña, M; Orellana, MA; Origuen, J; San-Juan, R	1
Castagnola, E; Lo Porto, D; Mularoni, A; Saffioti, C	1
Bi, Z; Chen, C; Hamilton, MJ; Khoruts, A; Roy, S; Sadowsky, MJ; Su, R; Zhang, L; Zhou, Y	1
Cacace, J; Goldman, DL; Lee, P; Nemati, K; Silver, EJ	1
Garza, MA; Mathur, N; Nabbout, L; Quigley, EMM; Saleh, A; Thomas, B	1
Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M	1
Awad, MM; Cunningham, BA; Day, SL; Drinkwater, N; Hutton, ML; Lyras, D; McGowan, S; Singleton, J; Srikhanta, YN	1
Echevarria, K; Jones, M; Khader, K; Nelson, RE; Rubin, MA; Samore, MH; Stevens, VW; Timbrook, TT; Zhang, Y	1
Chow, A; Lye, DC; Ng, TM; Tay, HL	1
Burger, A; Pahwa, AK; Parsons, AS	1
Achonu, C; Garber, G; Johnstone, J; Katz, KC; Li, Y; Ling, R	1
Garey, KW	1
Brown, SV; Johnson, SW; Priest, DH	2
English, M; Fukushima, A; Okumura, H; Shoji, S; Taieb, V	1
Gasbarrini, A; Gisbert, JP; Hold, GL; Malfertheiner, P; Megraud, F; O'Morain, C; Rokkas, T; Tilg, H	1
Allegretti, JR; Bry, L; Gerber, GK; Kennedy, K; Marcus, J; Sitko, J; Storm, M	1
Atamna, A; Avni, T; Ayada, G; Babitch, T; Ben-Zvi, H; Bishara, J; Hijazi, R	1
Cimolai, N	1
Andersen, M; Lei, DK; Ollech, JE; Rubin, DT; Sossenheimer, P; Weisshof, R; Zmeter, N	1
Freedberg, DE; Gomez-Simmonds, A; Li, J; Salmasian, H; Schluger, A; Wang, Y	1
Basiliere, E; Beldavs, ZG; Davis, CM; Dumyati, GK; Farley, MM; Gerding, DN; Guh, AY; Holzbauer, SM; Johnston, H; Kainer, M; Mu, Y; Novosad, SA; Ocampo, VLS; Olson, DM; Perlmutter, R; Phipps, EC; Revis, A; Whitten, T; Wilson, L; Winston, LG	1
Kociolek, LK	1
Bosis, S; Bradford, D; Croos-Dabrera, R; Fortuny, C; Incera, E; Kalocsai, K; Korczowski, B; Lazar, S; Melis, J; Petit, A; van Maanen, R; Wolf, J	1
Quigley, EMM	1
Buckley, AM; Chilton, CH; Clark, E; Ewin, D; Moura, IB; Normington, C; Wilcox, MH	1
Bondarenco, M; Kachlon, Y; Lazarovitch, T; Marchaim, D; Mengesha, B; Strul, N; Toledano, L; Youngster, I; Zaidenstein, R; Zilberman-Itskovich, S	1
Lacy Smith, K; Mounsey, A; Nickolich, S; Reddy, VC	1
Chan, PKS; Jiang, X; Lee, WH; Ng, SC; You, JHS	1
Cawcutt, K; Cortes-Penfield, N; McCreery, R; Van Schooneveld, T	1
Kimura, T; Stanhope, S; Sugitani, T	1
Piotrowski, M; Pituch, H; Wultańska, D	1
Malani, PN; Rao, K	1
Aoki, K; Chono, K; Ishii, Y; Konishi, H; Tateda, K; Yamaguchi, T	1
English, M; Okumura, H; Shoji, S; Ueyama, M	1
AbdelKhalek, A; Ghosh, C; Haldar, J; Mohammad, H; Seleem, MN	1
Boggiano, VL; Smith, KL; Sullivan, MH	1
Ebisui, A; Goto, R; Inose, R; Ishii, S; Kawabe, A; Kusama, Y; Muraki, Y; Ohmagari, N; Yagi, T	1
Adams, V; Athan, E; Guest, G; Larcombe, S; Liew, KC; Nagra, SS; Walker, HN	1
Banoub, M; Blackman, AL; Claeys, KC; Heil, EL; Kristie Johnson, J; Leekha, S; Vega, AD	1
Dai, W; Niu, S; Sun, J; Wang, Z; Xia, Y; Yan, L; Yang, T; Zhang, C	1
Chankhamhaengdecha, S; Harnvoravongchai, P; Janvilisri, T; Ounjai, P; Phanchana, M; Phetruen, T; Raksat, P	1
Cheng, JW; Fan, X; Hou, X; Kudinha, T; Liang, GW; Liu, C; Shao, DH; Su, JR; Wang, Y; Wei, M; Xiao, M; Xiong, ZJ; Xu, YC; Yang, CX; Yang, QW; Yu, SY	1
Athan, E; Roder, C	1
Abutaleb, NS; Seleem, MN	1
Abolghasemi, S; Mardani, M; Shabani, S	1
Dubrovskaya, Y; Phillips, MS; Zacharioudakis, IM; Zervou, FN	1
Alomari, M; Babar, S; El Iskandarani, M; El Kurdi, B; Haddad, I; Imam, Z; Moorman, J; Myers, J	1
Bickett-Burkhart, K; Chalasani, N; Fischer, M; Gandhi, D; Orman, ES; Phatharacharukul, P; Purpura, RD; Xu, H	1
Alrahmany, D; El Nekidy, WS; Ereshefsky, BJ; Ghazi, IM; Pontiggia, L	1
Gutin, LS; Lam, AY; Nguyen, Y; Velayos, FS	1
Hurley, JC	1
Bernstein, CN; Kao, D; Lee, C; Rubin, DT; Shaffer, SR; Singh, H; Smieliauskas, F; Targownik, LE; Witt, J	1
Abe, T; Hirata, K; Morikawa, K; Nozaki, M; Wada, K; Yanagihara, I	1
Aroniadis, O; Cruz, C; Frenette, PS; Goldman, DL; Herold, BC; Lee, P; Manwani, D; Sinha, AA; Soma, VL; Wang, T	1
Ito, H	1
Banoub, M; Blackman, A; Claeys, KC; Heil, EL; Johnson, JK; Leekha, S; Vega, A	1
Benes, J; Capek, V; Krutova, M; Polivkova, S; Sykorova, B	1
Amjad, T; Becker, S; Behera, GK; Chen, J; Cho, JM; Cunningham, SA; Dunny, G; Greenwood-Quaintance, KE; Jeraldo, PR; Jones-Hall, Y; Kashyap, PC; Mendes-Soares, H; Patel, R; Pu, M	1
Abad, D; Alfaro, E; Cañamares, P; García, S; Hernández, M; Hijos, G; Laredo, V; Lorente, S; Saura, N; Velamazán, R	1
Dong, J; Du, W; Han, W	1
Sugimoto, H; Sugimoto, K; Yamamoto, T; Yoshihara, A	1
Lodise, TP; Lowry, C; Morgenson, D; Patel, N; Shah, V; Stornelli, N	1
Campbell, DL; Gentry, CA; Williams, RJ	1
Bryant, JA; Buckley, AM; Clark, EV; Davis, G; Ewin, DJ; Ford, CB; Harris, HC; Henn, MR; Kettle, MJ; Moura, IB; Normington, C; Spittal, W; Wilcox, MH	1
Brown, SC; Chiari, EF; Gerding, HR; Gisch, K; Kiessig, ST; Mandago, M; Pulse, M; Simon, MR; von Eichel-Streiber, C; Weiss, W	1
Coe, K; Reed, EE; Rinaldi, A; Smith, JM; Stevenson, KB	1
Hopp, J; Omecene, NE; Orndahl, CM; Pakyz, AL; Stultz, JS	1
Andersen, CØ; Bytzer, P; Chehri, M; Engberg, J; Helms, M; Heno, KK; Jensen, US; Krogsgaard, LR; Petersen, AM; Ribberholt, I; Rode, AA; Schønning, K; Svendsen, AT; Tvede, M	1
Adelman, MW; Fridkin, SK; Goodenough, D; Mackey, C; Sefton, S; Thomas, S; Woodworth, MH	1
Chen, J; Deresinski, S; Gong, CL; Hay, JW; Hitchcock, MM; Holubar, M	1
Sachan, A; Shankar, S; Singh, AR	1
Addison, B; Addison, RM; Anderson, DJ; Gergen-Teague, MF; Rutala, WA; Sexton, DJ; Turner, NA; Warren, BG; Weber, DJ	1
Enoki, Y; Hasegawa, N; Iketani, O; Matsumoto, K; Misawa, K; Taguchi, K; Uno, S; Uwamino, Y	1
Jane, F; Jon J, V; Mark H, W	1
Barbut, F; Bémer, P; Berger, P; Bessède, E; Camou, F; Cattoir, V; Couzigou, C; Descamps, D; Dinh, A; Gauzit, R; Gourdon, M; Guery, B; Laurans, C; Lavigne, JP; Le Monnier, A; Lechiche, C; Leflon-Guibout, V; Levast, M; Mootien, JY; N'Guyen, Y; Piroth, L; Prazuck, T; Rogeaux, O; Roux, AL; Vachée, A; Vernet Garnier, V; Wallet, F	1
Boban, N; Goić-Barišić, I; Lukšić, B; Novak, A; Radić, M; Rubić, Ž; Tonkić, M	1
Chiu, CW; Hung, YP; Ko, WC; Lee, CC; Tsai, PJ	1
Bao, H; Dubrovskaya, Y; Jen, SP; Lighter, J; Merchan, C; Papadopoulos, J; Siegfried, J	1
Khodaparast, S; Khoramabadi, N; Mohabati Mobarez, A; Saberifiroozi, M; Vasei, M	1
Trafford, G	1
Kim, YJ; Kim, YK; Kwon, HI; Lee, HS; Lee, JC; Lee, WK; Na, SH; Nicholas, A; Selasi, GN; Shin, JH; Song, KE	1
Shin, JH; Warren, CA	1
Deck, K; Gerding, DN; Hazan, S; Lucasti, C; Maliakkal, B; Nathan, R; Pesant, Y; Pullman, J; Roblin, D; Tejura, B; Tillotson, GS; Vickers, RJ; Wilcox, MH; Yacyshyn, B	1
Alcalá, L; Bouza, E; de Egea, V; González-Del Vecchio, M; Marín, M; Muñoz, P; Reigadas, E; Valerio, M	1
Axelrad, JE; Green, PHR; Joelson, A; Lawlor, G; Lebwohl, B; Lichtiger, S; Nobel, YR	1
Chan, FKL; Chan, MCW; Chan, PKS; Cheung, K; Ching, JYL; Lam, K; Lui, R; Ng, SC; Sung, JJY; Tang, W; Wong, SH; Wu, JCY; Yu, J; Zuo, T	1
Allen, S; DiBaise, JK; Griesbach, CL; Hartmann, CA; Kosiorek, HE; Orenstein, R; Patron, RL	1
Bachmann, O; Dersch, P; Solbach, P	1
Gerding, DN; Johnson, S; Lum, J; Manzo, C; Sirbu, BD; Soriano, MM	1
Leidi, F; Wu, MA	1
Branch-Elliman, W; Gupta, K; Itani, KMF; O'Brien, WJ; Perencevich, E; Ripollone, JE; Schweizer, ML; Strymish, J	1
Cheng, JW; Kong, F; Kudinha, T; Liao, JW; Xiao, M; Xu, YC; Yang, QW; Yu, SY; Zhou, ML	1
Bhala, N; Iqbal, TH; Moore, D; Price, M; Quraishi, MN; Sharma, N; Widlak, M	1
Brodsky, D; Jackson, K; Nitzan, O; Pastukh, N; Peretz, A; Tkhawkho, L	1
Chen, HX; Luo, YP; Shen, YY; Song, LJ; Suo, L; Wang, R	1
Anderson, FA; Ayturk, MD; Collins, CE; Psoinos, CM; Santry, HP	1
DeMelo, V; Jones, PM; Kidane, B; McCreery, G; Mele, T	1
Auchtung, J; Boonma, P; Britton, RA; Brown, A; Dann, SM; Haag, A; Luna, RA; Oezguen, N; Peniche, A; Ross, CL; Runge, J; Savidge, TC; Spinler, JK; Versalovic, J	1
Eckmann, L; Fuhrmann, V; Manthey, CF	1
Battat, R; Bessissow, T; D'Aoust, J	1
Blanco, N; Eisenberg, MC; Foxman, B; Malani, AN; Rickard, AH; Walk, S; Zhang, M	1
Carignan, A; Couture-Cossette, A; Ilangumaran, S; Valiquette, L	1
Boyle, E; Galperine, T; Guery, B; Héquette-Ruz, R; Herbaux, C; Robin, C	1
Descourouez, JL; Jorgenson, MR; Kerstenetzky, L; Leverson, GE; Redfield, RR; Saddler, CM; Safdar, N; Smith, JA; Splinter, LE	1
Álvarez-Lobos, M; Díaz-González, F; Paredes-Sabja, D; Pizarro-Guajardo, M	1
Iguchi, M; Kuzuya, T; Mikamo, H; Morioka, H; Yagi, T	1
Burton, HE; Mitchell, SA; Watt, M	1
Byrne, B; Cannon, K; Chesnel, L; Happe, J; Louie, T; Ward, L; Wu, K	1
Adedoyin, A; Chesnel, L; Daley, P; Guris, D; Jin, M; Khanna, S; Larson, KB; Louie, T; Lutz, JE; Murata, Y; Stoutenburgh, U	1
Backo, JL; Broderick, KC; Corvino, FA; Reveles, KR; Zivkovic, M	1
Aoyama, N; Dorr, MB; Fujimoto, G; Mikamo, H; Sawata, M; Yoshinari, T	1
Cossrow, N; Dorr, MB; Dubberke, ER; Elbasha, E; Jiang, Y; Marcella, S; Prabhu, VS	1
Kupiec, KE; Liu, C; Miller, JL; Schmidt, SA; Skrepnek, GH; Smith, WJ; Tieu, JD	1
Andoh, A; Bamba, S; Imaeda, H; Inatomi, O; Nishida, A; Sasaki, M; Sugimoto, M	1
Chen, YB; Fang, YH; Gu, SL; Li, LJ; Lv, T; Shen, P; Tang, LL	1
Gaur, AH; Huskey, RL; Inaba, H; Ribeiro, R; Rubnitz, JE; Sun, Y; Tang, L; Wolf, J	1
Baines, SD; Camacho-Ortiz, A; Garcia-Mazcorro, JF; Garza-González, E; Gutiérrez-Delgado, EM; Maldonado-Garza, H; Martínez-Meléndez, A; Mendoza-Olazarán, S; Palau-Davila, L	1
Gerding, DN	2
Barac, A; Jevtovic, D; Jordovic, J; Katanic, N; Korac, M; Markovic, A; Milosevic, B; Milosevic, I; Mitrovic, N; Nesic, Z; Popovic, N; Urosevic, A	1
Maric, LS; Papic, N; Vince, A	1
Bishop, EJ; Botha, J; Kelley, PG; Marshall, C; Metcalfe, J; Tiruvoipati, R	1
Jamot, S; Kelly, CR; Lim, SH; Patel, K; Raghunathan, V	1
Chahine, EB	1
Chang, HJ; Chen, CL; Chia, JH; Chiu, CH; Chuang, CH; Kuo, AJ; Lai, HC; Lu, CC; Su, LH; Wu, TL; Wu, TS	1
Ajami, NJ; Chesnel, L; Cope, JL; Petrosino, JF; Wong, MC	1
Araj, GF; Becker, SL; Berger, FK; Bischoff, M; Dbaibo, G; Gärtner, B; Karaoui, WR; Mahfouz, R; Matar, GM; Rasheed, SS; Rimmani, HH; Sharara, AI; von Müller, L	1
Abe, K; Furukawa, K; Ishida, Y; Sakamoto, T; Shiba, H; Yanaga, K	1
Anders, S; Garcia-Diaz, J; Hand, J; Li, J; Nguyen, CT; Staffeld-Coit, C	1
Goyal, H; Perisetti, A; Rehman, MR; Singla, U	1
Lübbert, C; von Braun, A	1
Dorr, MB; Dubberke, ER; Ellison, MC; Eves, K; Gerding, DN; Guris, D; Hanson, ME; Kao, D; Kelly, CP; Kumar, PN; Lee, C; Rahav, G; Yacyshyn, B	1
Adler, A; Carmeli, Y; Cohen, D; Miller-Roll, T; Na'amnih, W	2
Arakawa, S; Fujisawa, M; Kinugawa, S; Kitagawa, K; Nakanishi, N; Osawa, K; Shigemura, K; Tokimatsu, I; Yoshida, H	1
de With, K; Helbig, S; Wilke, K	1
Chang, J; McDermott, LA; Snydman, DR; Thorpe, CM; Vickers, RJ; Walk, ST; Wick, J	1
Cornely, OA; De Nigris, E; Goldenberg, SD; McCrea, C; Watt, M	1
Bondorenco, M; Dadon, M; Daniel, C; Kachlon, Y; Lazarovitch, T; Marchaim, D; Mengesha, B; Toledano, L; Youngster, I; Zaidenstein, R	1
Drennan, K; Fabian, J; Gaylard, PC; Hepple, A; Karlsson, K; Lee, S; Lowman, W; McNamara, L; Simons, G	1
Cammarota, G; Gasbarrini, A; Ianiro, G; Lopetuso, LR; Masucci, L; Quaranta, G; Sanguinetti, M; Simonelli, C	1
Mullish, BH; Williams, HR	1
Bernardy, J; Faldyna, M; Krejčí, J; Krutova, M; Matejkova, J; Nyc, O; Tkadlec, J; Zouharova, M	1
Lv, Z; Su, J; Wang, B; Zhang, P	1
Barbosa, KVBD; Chebli, JMF; Chebli, LA; Costa, LA; da Rocha Ribeiro, TC; de Almeida Cruz, W; de Assis, IC; de Lima Pace, FH; Gaburri, PD; Garcia, PG; Moraes, BRM; Zanini, A	1
Abhyankar, S; Clough, L; Ganguly, S; Grauer, D; Lin, T; Mahmoudjafari, Z; McGuirk, J; Prohaska, L; Shune, L; Singh, A	1
Gamo, K; Hashimoto, A; Kato, K; Kusachi, S; Mikamo, H; Miki, T; Oizumi, Y; Takesue, Y; Tateda, K; Toyoshima, J; Yanagihara, K	1
Alexandre, S; Amaratunga, KR; Choi, KB; Collet, JC; Davis, I; Du, T; Evans, GA; Frenette, C; Golding, GR; Gravel, D; Hota, S; Katz, KC; Kibsey, P; Langley, JM; Lee, BE; Lemieux, C; Longtin, Y; Mertz, D; Mieusement, LMD; Minion, J; Moore, DL; Mulvey, MR; Pelude, L; Richardson, S; Science, M; Simor, AE; Stagg, P; Suh, KN; Taljaard, M; Taylor, G; Thampi, N; Wong, A	1
Wilson, A	1
Aliramezani, A; Baghani, A; Douraghi, M; Ghourchian, S; Mesdaghinia, A; Yaseri, M	1
Chalfin, DB; Delgado, D; Fraser, TG; Lam, SW; Neuner, EA	1
Aldape, MJ; Bayer, CR; Bryant, AE; Rice, SN; Stevens, DL	1
Abel-Santos, E; Estrada, A; Hedlund, BP; Howerton, A; Liao, Z; Mefferd, CC; Murugapiran, SK; Phan, JR; Seymour, CO; Wagner, AJ	1
Ip, M; Jiang, M; Leung, NH; You, JHS	1
Birchall, S; Corbett, D; Locher, HH; Skinner, K; Thommes, P	1
Biesiada, G; Birczyńska, M; Czepiel, J; Garlicki, A; Jędrychowski, M; Michalak, M; Pejka, K; Sobczyk-Krupiarz, I	1
Chang, J; Kane, AV; Snydman, DR; Tai, A; Thorpe, CM; Vickers, RJ	1
Bennett-Wood, V; Hocking, D; Lyras, D; Mackin, KE; Robins-Browne, RM; Srisuwan, S; Voravuthikunchai, SP	1
Enoki, Y; Igarashi, Y; Kunishima, H; Matsumoto, K; Mikamo, H; Mori, N; Morinaga, Y; Nakamura, A; Ohge, H; Suzuki, H; Taguchi, K; Tashiro, S; Yamagishi, Y; Yanagihara, K; Yoshizawa, S	1
Cifu, AS; Gupta, A; Khanna, S	1
Asundi, A; Barón, AE; Branch-Elliman, W; Gold, H; Gupta, K; Ho, PM; Mehta, P; Mull, H; Stanislawski, M	1
Boota, N; Bradshaw, L; Diggle, M; Jawhari, A; Major, G; Montgomery, A; Spiller, RC; Sprange, K	1
Babushok, DV; Frey, NV; Freyer, CW; Ganetsky, A; Gill, SI; Gilmar, C; Han, JH; Hexner, EO; Hughes, ME; Loren, AW; Luger, SM; Mangan, JK; Martin, ME; Porter, DL; Schuster, M; Smith, J; Stadtmauer, EA	1
Cho, S; Dubinsky, MC; Grinspan, A; Hirten, R; Spencer, E	1
Fernández Lisón, LC; Malpartida Flores, M; Martín Rizo, L	1
Gentry, CA; Skrepnek, GH; Tieu, JD; Williams, RJ	1
Bohm, NM; Brown, CC; Curry, SR; Manis, MM	1
Batista, R; Davido, B; Denis, M; Dinh, A; Escaut, L; Fessi, H; Lawrence, C; Michelon, H; Perronne, C; Salomon, J	1
Appaneal, HJ; Caffrey, AR; LaPlante, KL	1
Gentry, CA; Kurdgelashvili, G; Nguyen, PK; Skrepnek, GH; Thind, S; Williams, RJ	1
Dahl Jørgensen, SM; Dahlerup, JF; Erikstrup, C; Hansen, MM; Hvas, CL; Jørgensen, SP; Lemming, L; Storgaard, M	1
Abouanaser, S; Beckett, P; Lee, C; Smieja, M; Stankus, V; Zhang, K	1
Amirmozafari, N; Baseri, Z; Douraghi, M; Fakhre Yaseri, H; Kouhsari, E; Krutova, M; Moqarabzadeh, V; Sholeh, M; Talebi, M	1
Gross, AE; Sarna, KV	1
Berger, F; Jazmati, N; Piepenbrock, E; Stelzer, Y	1
Baggs, J; Guh, A; Hatfield, KM; Jernigan, JA; Kazakova, SV; McDonald, LC; Reddy, SC; Yi, SH	1
Cosh, J; Kennedy, K; Ong, CW; Sukumaran, V; Thammavong, A	1
Boyanova, L; Hadzhiyski, P; Markovska, R; Mitov, I; Yaneva, P; Yordanov, D	1
Ramesh, MS; Yee, J	1
Eiferman, DS; Evans, DC; Feeney, ME; Gerlach, AT; Murphy, CV; Rushing, A; Thompson, M	1
Adomakoh, N; Cornely, OA; Georgopali, A; Guery, B; Karas, A; Kazeem, G; Vehreschild, MJGT	1
Albert, E; Madhav, D; Mollie, J; Muhammad, A; Prateek, S; Rawish, F; Viveksandeep, TC	1
Kimura, T; Snijder, R; Sugitani, T	1
Aguado, JM; Almirante, B; Cobo, J; González Antona Sánchez, E; Grau, S; López Gutiérrez, C; Rubio-Rodríguez, D; Rubio-Terrés, C; Salavert, M	1
Calderwood, MS; Caroff, DA; Klompas, M; Kubiak, DW; Menchaca, JT; Rhee, C; Yokoe, DS; Zhang, Z	1
Balen Topić, M; Bogdanić, N; Vidović, K	1
Chen, CL; Cheng, CW; Chia, CY; Chiu, CH; Deng, ST; Hsiao, HL; Lee, HY; Tsai, TC	1
Bajrovic, V; Brizendine, KD; Budev, M; McCurry, KR	1
Berthiller, J; Chardot, C; Duclaux-Loras, R; Ferroni, A; Goulet, O; Lacaille, F; Norsa, L	1
Alvarez, AM; Rathore, MH	1
Abidi, MZ; Bajrovic, V; Barber, GR; Benamu, E; Chase, S; Fish, DN; Gutman, JA; Kaiser, JN; Miller, MA; Morrisette, T; Mueller, SW; Tobin, J; Van Matre, AG	1
Burhenne, J; Foerster, KI; Haefeli, WE; Höne, RT; Merle, U; Mohr, I; Sauter, M; Uhl, P	1
Bryson-Cahn, C; Chan, JD; Jain, R; Liu, C; Lynch, JB	1
Baines, SD; Camacho-Ortíz, A; Flores-Treviño, S; Garza-González, E; Maldonado-Garza, H; Morfín-Otero, R; Rodríguez-Noriega, E; Tijerina-Rodríguez, L; Villarreal-Treviño, L	1
Albert, E; Ali, N; Muhammad, A; Rawish, F; Sabih, R; Simcha, W	1
Bauer, MP; Debast, SB; Kuijper, EJ; Sanders, IM; Wilcox, MH	1
Abel-Santos, E; Howerton, A; Patra, M	1
Dupont, HL	3
Cherifi, S; Cytryn, E; Delmée, M; Karmali, R; Mascart, G; Van Broeck, J	1
Beamer, G; Bowlin, T; Butler, M; Steele, J; Tzipori, S; Zhang, Q	1
Falcone, M; Giuliano, S; Guastalegname, M; Russo, A; Venditti, M	1
Beyda, ND; Garey, KW; Jardin, CG; Jiang, Z; Le, F; Palmer, HR; Shah, DN	1
Jindai, K; Kunzer, B; O'Horo, JC; Safdar, N	1
Baji, P; Banai, J; Brodszky, V; Gulácsi, L; Kertész, A; Kopcsóné Németh, I; Ludwig, E; Péntek, M; Prinz, G; Reményi, P; Strbák, B; Zsoldiné Urbán, E	1
Bass, SN; Bauer, SR; Lam, SW; Neuner, EA	3
Tart, SB	1
Chilton, CH; Crowther, GS; Freeman, J; Longshaw, CM; Nicholson, S; Todhunter, SL; Wilcox, MH	1
Abujamel, T; Cadnum, JL; Donskey, CJ; Jump, RL; Jury, LA; Kundrapu, S; Stintzi, AC; Sunkesula, VC	1
Kaufman, E; Liska, D; Nandakumar, G; Rubinshteyn, V	1
Babakhani, F; Crook, DW; Del Ojo Elias, C; Eyre, DW; Gorbach, SL; Griffiths, D; Peto, TE; Seddon, J; Walker, AS	1
Keller, JM; Surawicz, CM	1
Chen, X; Enderlin, M; Fournier, E; Hubschwerlen, C; Keck, W; Kelly, CP; Klenk, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S; Seiler, P	1
Curry, SR; Marsh, JW	1
Collins, SH; D'Agostino, RB; Gorbach, S; Kean, Y; Pencina, KM	1
Goering, RV; Lynn, AN; Persing, DH; Tenover, FC; Tickler, IA; Whitmore, JD	1
Wilcox, MH	1
Broom, C; Chasan-Taber, S; Cornely, OA; Davidson, DM; Fitts, D; Gelone, SP; Gerding, DN; Johnson, S; Louie, TJ	1
Miigoć, H; Piekarska, M; Wandałowicz, AD	1
Berel, D; Dezfoli, S; Dubinsky, M; Fleshner, P; Grein, J; Hirsch, J; Horton, HA; Ippoliti, A; Kaur, M; McGovern, D; Melmed, GY; Murthy, R; Shih, D; Targan, SR; Vasiliauskas, EA	1
Hagel, S; Stallmach, A; Weber, M	1
Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M	1
Seril, DN; Shen, B	1
Pulse, M; Vickers, R; Weiss, W	1
Aitken, SL; DuPont, HL; Garey, KW; Joseph, TB; Lasco, TM; Palmer, HR; Shah, DN; Xie, Y	1
Cornely, OA; Ivanescu, C; Nathwani, D; Odeyemi, IA; Odufowora-Sita, O; Retsa, P	1
Brunetti, G; Ghezzi, MC; Raponi, G; Visconti, V	1
Cornely, OA; Nathwani, D; Odeyemi, IA; Odufowora-Sita, O; Retsa, P; Van Engen, AK	1
Chen, PL; Hung, YP; Ko, WC; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wu, CJ; Wu, YH; Yeh, FH	1
Grimm, M; Rafael, T	1
Bhanot, N; Chan-Tompkins, NH; Goswami, R; McEllistrem, MC; McGraw, M; Sahud, AG	1
Froom, P	1
Bell, S; Buxey, KN; Sia, C; Wale, R; Warrier, SK; Wein, D	1
Biltaji, E; Jensen, MK; LaFleur, J; Nelson, RE; Roberts, MS; Smith, KJ; Varier, RU	1
Dees, A; Jonkman, JG; van Genderen, ME; van Rijn, M	1
Bhansali, SG; Dabovic, K; Leeds, JA; Mullane, K; Pertel, P; Praestgaard, J; Ting, LS	1
Blais, J; Bressler, A; Buitrago, M; Dabovic, K; Lee, C; Leeds, JA; Mullane, K; Pertel, P; Praestgaard, J; Weiss, K	1
Johnson, S; Soriano, MM	1
Bass, JA; Butler, D; McCulloh, R; Myers, A; Pahud, B; St Peter, SD; Torres-Torres, S	1
Dull, RB; Hill, S; Klick, A; McCoy, RM	1
Payne, L; Sattar, A; Thommes, P; Vickers, RJ; Warn, P	1
Carver, PL; DePestel, DD; Eyler, R; Fohl, AL; Pettit, NN	1
Dubberke, ER; Olsen, MA; Reske, KA; Yan, Y; Zilberberg, M	1
Carfagna, P; Falcone, M; Fantoni, M; Ghezzi, MC; Masucci, L; Murri, R; Posteraro, B; Russo, A; Sanguinetti, M; Venditti, M	1
Biswas, JS; Goldenberg, SD; Newsholme, W; Otter, JA; Patel, A; van Kleef, E; Wade, P	1
Bibbò, S; Cammarota, G; Costamagna, G; Dinoi, G; Gasbarrini, A; Ianiro, G; Masucci, L; Sanguinetti, M	1
Jang, BI; Kim, YG	1
Byrne, B; Cannon, K; Emery, J; Krulicki, W; Louie, TJ; Nguyen, D; Ward, L; Wu, K	1
Chilton, CH; Crowther, GS; Freeman, J; Nicholson, S; Todhunter, SL; Wilcox, MH	1
Carter, GP; Elliott, B; Howden, BP; Jenkin, GA; Korman, TM; Kotsanas, D; Lyras, D; Mackin, KE; Riley, TV; Rood, JI	1
Nicolau, DP; Thabit, AK	1
Cook, GK; Fischer, M; Rex, DK; Robb, BW; Rogers, NA; Sipe, BW; Vuppalanchi, R	1
Vaishnavi, C	2
Adler, A; Block, C; Bradenstein, R; Carmeli, Y; Mendelson, B; Miller-Roll, T; Paitan, Y; Parizade, M; Peled, N; Schwaber, MJ; Schwartz, D	1
Gademann, K; Hattori, H; Kaufmann, E; Miyatake-Ondozabal, H	1
Cai, P; Chen, L; Cheng, G; Dai, X; Li, Z; Wang, Z; Zhang, Z	1
Acuña, G; Moscoso, F; Quera, R; Rivera, D; Simian, D	1
Doron, S; Gorbach, S; Mizusawa, M	1
Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Kracker, H; Louie, T; Nord, CE; Talbot, GH; Wilcox, M	1
Danielsen, TK; Holt, HM; Justesen, US	1
Downham, G; Gallagher, JC; Haynes, K; Navalkele, B; Reilly, JP; Trivedi, M	1
Cammarota, G; Fantoni, M; Gasbarrini, A; Ianiro, G; Pecere, S; Sabatelli, M	1
Fischer, M; Rex, DK; Sipe, BW	1
Anguita, P; Cobo Reinoso, J; Gani, R; Grau Cerrato, S; Mensa Pueyo, J; Rubio-Rodríguez, D; Rubio-Terrés, C; Salavert Lletí, M; Toledo, A; Watt, M	1
Best, E; Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Hecht, DW; Kracker, H; Locher, HH; Louie, T; Nord, CE; Osmolski, JR; Sambol, S; Talbot, GH; Wilcox, M	1
Cojocariu, C; Girleanu, I; Miftode, E; Singeap, AM; Stanciu, C; Stoica, O; Trifan, A	1
Carfagna, P; Falcone, M; Goldoni, P; Iraci, F; Russo, A; Venditti, M; Vullo, V	1
Jacobson, SM; Slain, D	1
Gelijns, AC; Koll, BS; Mazumdar, M; Meyer, J; Moskowitz, A; Poeran, J; Rasul, R; Sacks, HS; Wallach, FR	1
Bowie, WR; Bryce, EA; Forrester, LA; Lau, TT; Steiner, TS; Yeung, JK; Yeung, SS	1
Freeman, J; Vernon, J; Vickers, R; Wilcox, MH	1
Almendares, O; Cleveland, AA; Farley, MM; Lessa, FC; Magill, SS; Reno, J; Smith, RM; Smith, ZT; Stein, B; Vallabhaneni, S	1
Bolick, DT; Coquery, CM; Erickson, LD; Kolling, GL; Loo, WM; Moore, JH; Shin, JH; van Opstal, E; Wade, NS; Warren, CA	1
Alam, MJ; Garey, KW; Khaleduzzaman, M; Nicolau, DP; Thabit, AK	1
Dubberke, ER; Gerding, DN; Kelly, CP; Mahé, C; Olsen, MA; Saeed, MJ; Stwalley, D; Young-Xu, Y	1
del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T	1
Kautza, B; Zuckerbraun, BS	1
Bryant, AM; Crannage, AJ; Hennessey, EK; Khoury, JA; Manian, FA; Van Hise, NW	1
Brodsky, D; Halevi, CN; Nitzan, O; Pastukh, N; Peretz, A; Tkhawkho, L	1
Cornely, OA; Vehreschild, MJ	1
Telekes, A	1
Zar, FA	1
Chesnel, L; Lee, CH; Louie, T; Mullane, KM; Patino, H; Rege, S; Stevens, C	1
Winn, R; Zhu, KJ	1
Dorsch, MP; Early, CR; Hanigan, SM; Park, JM; Pogue, KT	1
Black, T; Corbett, D; Flattery, A; Hernandez, LD; Sattar, A; Therien, AG; Thommes, P; Warn, P; Zhang, Z	1
Cheng, MP; Lee, TC; Parkes, LO	1
Al-Bachari, H; Carignan, A; Labbé, AC; Martin, P; Montpetit, LP; Pépin, J; Poulin, S; Valiquette, L	1
Baumgartner, LJ; Brown, L; Geier, C	1
Chan, EW; Choi, NK; Griffiths, J; Jin, XM; Kimura, M; Kimura, T; Kubota, K; Lai, EC; Lee, J; Man, KK; Nguyen, TA; Ooba, N; Park, BJ; Pratt, NL; Roughead, EE; Sato, T; Shin, JY; Wang, T; Wong, IC; Yang, YK	1
Eckmann, C; Lyon, S	1
Cooper, P; Groß, U; Gunka, K; Janssen, I; Rupnik, M; Wetzel, D; Zimmermann, O	1
Boccuzzi, E; Borali, E; Castellazzi, L; Cursi, L; De Giacomo, C; De Vita, MV; Esposito, S; Garazzino, S; Guarino, A; Lancella, L; Lo Vecchio, A; Mainetti, M; Tagliabue, C	1
Chen, X; D'Auria, G; Duan, Y; Džunková, M; Huang, J; Kelly, CP; Moya, A; Xu, H	1
Kriz, Z; Krutova, M; Kubicek, L; Kuijper, E; Matejkova, J; Nyc, O; Ruzicka, F; Tejkalova, R	1
Fashandi, AZ; Friel, CM; Hallowell, PT; Hays, RA; Hedrick, TL; Martin, AN; Smith, PW; Wang, PT	1
Bohm, M; Cheng, YW; Fischer, M; Kassam, Z; Phelps, E; Rogers, N; Sagi, S; Sipe, B; Xu, H	1
Gerding, DN; Johnson, S	1
Akbari, M; Alonso, CD; Castillo, N; Kelly, CP; Leffler, DA; Patel, I; Theethira, T; Villafuerte-Galvez, J; Wungjiranirun, M	1
Brown, KA; Croft, LD; Glassman, P; Goetz, MB; Greene, T; Jones, MM; Khader, K; Nelson, RE; Neuhauser, M; Rubin, MA; Samore, MH; Schwab-Daugherty, EM; Stevens, VW	1
Balasubramanian, N; Fox-Geiman, M; Kang Martinez, E; Parada, JP; Scardina, TL; Smith, SE	1
Dinh, A; Le Monnier, A; Tilleul, P; Watt, M	1
Bartelsman, JF; Jansen, JM; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; van Heukelem, HA; van Nood, E; Visser, CE	1
Clark, T; Wiselka, M	1
Byker, GL; Dinh, MT; Gunaratnam, NT; Malani, AN; Robinson, EA; Shehab, TM	1
Cohen, MB	1
Cober, ED; Malani, PN	1
Janka, J; O'Grady, NP	1
Gerding, DN; Hecht, DW; Johnson, S; Patel, T; Patel, U; Schriever, C	1
Bauer, MP; Kuijper, EJ; van Dissel, JT	1
Bartlett, JG	6
Harpe, S; Oinonen, M; Pakyz, A; Polk, R; Schmiedeskamp, M	1
Al-Nassir, WN; Bobulsky, GS; Donskey, CJ; Nerandzic, MM; Sethi, AK	1
Spooner, LM; Sullivan, KM	1
Ambrosino, DM; Baxter, R; Blair, BM; Gerding, DN; Hay, CA; Leav, BA; Leney, M; Lowy, I; Molrine, DC; Nichol, G; Sloan, S; Thomas, WD	1
Aas, J; Gessert, CE; Rubin, TA	1
Gkrania-Klotsas, E; Nicholl, C; Parks, T; Wallis, S; Wilson, J	1
Shaw, W	1
Banaszkiewicz, A; Brazier, JS; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; van Belkum, A; Wultańska, D	1
Nyc, O	1
Byrne, B; Emery, J; Lawley, B; Louie, T; Munro, K; Tannock, GW; Taylor, C; Young, W	1
Carrier, JC; Fortier, LC; Frost, EH; Gonzales, M; Pepin, J; Sirard, S; Valiquette, L	1
Golan, Y; Gorbach, S; Lentnek, A; Louie, TJ; Miller, MA; Mullane, KM; Sears, P; Shue, YK; Weiss, K	1
Barman, TK; Bhatnagar, PK; Das, B; Kalia, V; Kumar, GR; Kumar, M; Mathur, T; Raj, VS; Singhal, S; Upadhyay, DJ	1
Balada-Llasat, JM; Buckosh, M; Hemminger, J; Pancholi, P; Raczkowski, M	1
Abraham, P; Desai, D; Deshmukh, A; Ingle, M; Joshi, A; Mankeshwar, R; Rodrigues, C	1
Craig, WA; Safdar, N	1
Gupta, K; Hermos, JA; Linsky, A	1
Chen, K; Davis, B; Feng, H; Sun, X; Wang, H; Zhang, Y	1
Cavanaugh, JE; Kuntz, JL; Laxminarayan, R; Polgreen, PM; Yang, M	1
Drekonja, DM	1
Tarchini, G	1
Baek, IH; Kim, HJ; Kim, JB; Lee, MS; Na, DK; Park, SH; Shin, SL; Shin, YC	1
Cocanour, CS	1
Dureuil, B; Gouin, P; Hariri, S; Tuech, JJ; Veber, B	1
Gorbach, S; Mullane, KM	1
Morrow, T	1
Alverdy, JC; Hall, DE; Neal, MD; Simmons, RL; Zuckerbraun, BS	1
Avdic, E; Carroll, KC; Cosgrove, SE; Lenhart, A; Maragakis, LL; Sydnor, ER; Trollinger, B	1
Kang, JO; Kim, J; Pai, H; Seo, MR	1
Baban, TA; El-Herte, RI; Kanj, SS	1
Malkan, AD; Scholand, SJ	1
Catanzaro, M; Cirone, J	1
Bliss, D; Butler, M; Drekonja, DM; Filice, GA; MacDonald, R; Rector, TS; Wilt, TJ	1
Kee, VR	1
Falagas, ME; Patouni, K; Polyzos, KA; Rafailidis, PI; Samonis, G; Vardakas, KZ	1
Chatterjee, AK; Millette, BH	1
Babakhani, F; Cheknis, A; Gerding, DN; Johnson, S; Kean, Y; Nagaro, K; Petrella, LA; Sambol, SP; Sears, PS	1
Donskey, CJ; Guerrero, DM; Jinno, S; Jury, LA; Kundrapu, S; Nerandzic, MM	1
Ballard, TE; Guerrant, RL; Hoffman, PS; Kennedy, A; Kolling, GL; Macdonald, TL; Olekhnovich, I; Riggins, M; van Opstal, E; Wang, X; Warren, CA; Warthan, M	1
Johnson, ES; Kuntz, JL; Neil, N; Petrik, AF; Raebel, MA; Smith, DH; Spindel, SJ; Thorp, ML; Yang, X	1
Crawford, T; Danziger, L; Huesgen, E	1
Cheema, FH; Kanwal, S; Korsten, MA; Luthra, M; Majeed, UM; Rafiullah, F; Sohail, MR	1
Anderson, DJ; Chen, LF	1
Citron, DM; Figueroa, I; Gerding, DN; Goldstein, EJ; Johnson, S; Sambol, SP	1
Allgren, RL; Sellers, S; Weiss, K	1
Crook, DW; Louie, TJ; Miller, MA; Sears, P; Weiss, K	1
Babakhani, F; Donskey, CJ; Miller, MA; Mullane, K; Nerandzic, MM	1
Byrne, B; Cannon, K; Emery, J; Eyben, M; Krulicki, W; Louie, TJ; Ward, L	1
Babakhani, F; Citron, DM; Goldstein, EJ	1
Bauer, MP; Dale, AP; Fawley, WN; Gerding, DN; Gorbach, SL; Hensgens, MP; Kuijper, EJ; Miller, MA; Wilcox, MH	1
Cornely, OA; Crook, DW; Gorbach, SL; Louie, TJ; Miller, MA	1
Babakhani, F; Bouillaut, L; Gomez, A; Nguyen, L; Sears, P; Sonenshein, AL	1
Johnson, S; Venugopal, AA	1
Angus, BJ; Cornely, OA; Crook, DW; Esposito, R; Gorbach, SL; Kean, Y; Louie, TJ; Miller, MA; Peto, TE; Stoesser, NE; Walker, AS; Weiss, K; Young, BC	1
Chilton, CH; Crowther, GS; Fawley, WN; Freeman, J; Lehoux, D; Marquis, M; Moeck, G; Todhunter, SL; Wilcox, MH	1
Baines, SD; Chilton, CH; Crowther, GS; Freeman, J; Todhunter, SL; Wilcox, MH	1
Bossé, D; Cantin, AM; Lemire, C; Ménard, F; Ruel, J; Valiquette, L	1
Farne, HA; Main, J; Martin, NK; Orchard, T; Tyrrell-Price, J	1
Bryant, A; Manian, FA	1
Anttila, VJ; Arkkila, P; Mattila, E; Mattila, PS; Tarkka, E; Tissari, P	1
Cornely, OA	1
Khanna, S; Pardi, DS	1
Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA	1
Bracken, TC; Figler, RA; Guerrant, RL; Kolling, G; Li, Y; Linden, J; Rieger, J; Stevenson, RW; Warren, CA	1
Harpe, SE; Inocencio, TJ; Oinonen, MJ; Pakyz, AL; Polk, RE	1
Li, Y; Qian, J; Queener, E; Shen, B	1
Chiba, J; Honda, Y; Kaku, M; Kunishima, H; Saito, M	1
Braga Neto, MB; Costa, LB; Guerrant, RL; Kolling, GL; Li, Y; Lima, AA; Oliveira, RA; Rodrigues, RS; Warren, CA; Zaja-Milatovic, S	1
Mann, SD; Pitt, J; Springall, RG; Thillainayagam, AV	1
Borderie, V; Bourcier, T; Laroche, L	1
Farr, BM; Giannetta, ET; Salgado, CD	1
Alary, ME; Chouinard, D; Forget, K; Pelletier, A; Pépin, J; Pépin, K; Valiquette, L; Villemure, P	1
Alex, P; Centola, M; Gillan, MM; Miner, J	1
McFarland, LV	1
Chek, K; Meadows, S; Ohl, ME; Stevermer, JJ; Tribuna, J	1
Parmar, MS	1
Alonso, R; Bouza, E; Muñoz, P	1
Bouza, E; Burillo, A; Muñoz, P	1
Owens, RC	1
Porath, A	1
Nazarko, L	1
Bishara, J; Paul, M; Wattad, M	1
Huggan, PJ; Murdoch, DR	1
Dubberke, ER; Gerding, DN; Johnson, S; Lawrence, SJ	1
Halsey, J	1
Scheurer, D	1
Funada, H; Hattori, K; Ishizaki, T; Kuroda, T; Nakamura, S	1
Gebhard, RL; Gerding, DN; Lee, JT; Olson, MM; Peterson, LR; Schwartz, MJ; Teasley, DG	1
Remington, H; Standing, VF	1
Gordon, RS	1
Batts, DH; Fekety, R; Green, EG; Hamilton, JP; Schwartz, JN; Silva, J; Stamper, L	1
Lamont, JT; Trnka, YM	1
McDonald, AJ; Milstone, EB; Scholhamer, CF	1
Lofgren, RP; Soltis, RD; Tadlock, LM	1
Pfitzner, U	1
Baer, M; Grönroos, P; Mäki, M; Vesikari, T	1
Eliopoulos, GM; Spitzer, PG	1
Koornhof, HJ; Miller, SD	1
Mehta, JB; Thomas, E	1
Dudley, MN; Gontarz, N; Nightingale, CH; Quintiliani, R	1
Burdon, DW; Hawker, PC; Hine, KR; Keighley, MR; Thompson, H	1
Brown, R; Wise, R	1
Wu, A	1
Bartlett, JG; Chang, TW; Flores, A; Grand, RJ; Sutphen, JL	1
Roberts, R; Seneviratne, E; Stafford, R; Walters, BA	1
Liston, TE	1
Gilligan, PH; Long, SS; Prebis, JW; Thompson, CM	1
Brabyn, DG; Chance, GW; Han, VK; Sayed, H; Shaheed, WA	1
Blake, M; Koornhof, HJ; Miliotis, M; Miller, SD; Still, C; Taubin, A	1
Tedesco, FJ	4
Arabi, Y; Bentley, S; Burdon, DW; Johnson, M; Keighley, MR; Mogg, GA; Youngs, D	1
Cudmore, MA; Fekety, R; Kim, KH; Liepman, MK; Silva, J	1
Fahrländer, H	1
Keighley, MR	1
Bartlett, JG; Chang, T; Lowe, B; Shull, S; Tedesco, FJ	1
Mikawa, M; Nakamura, S; Nakashio, S; Nishida, S; Okumura, S; Yamakawa, K	1
Faulkner, RS; Furlong, M; Haldane, EV; Kerr, EA; Marrie, TJ; Sidorov, J	1
Lamont, JT; Levine, HG	1
Burdon, DW	1
Finegold, SM; George, WL; Harding, GK; Klein, R; Putnam, CW; Rolfe, RD	1
Rampling, A; Swayne, RL; Warren, RE	1
Fekety, R; Kim, KH; Silva, J; Toshniwal, R	1
Bartlett, JG; Moskovitz, M	1
George, WL	2
Bartlett, JG; Viscidi, RP	1
Berman, MM; Helgason, H; Hyams, JS	1
Baird, I; Batts, DH; Fekety, R; Plouffe, JF; Rifkin, GD; Silva, J	1
Bartlett, JG; Cisneros, RL; Onderdonk, AB	1
Batts, DH; Fekety, FR; Holmes, R; Martin, D; Silva, J	1
Bartlett, JG; Mendelow, H; Wald, A	1
Moore, B; Philpot, CR; Rich, G; Wilkinson, IJ	1
Finegold, SM; George, WL; Rolfe, RD	1
Friedman, RJ; Galambos, JT; Hersh, T; Mayer, IE	1
Bowman, RA; Riley, TV	1
Roberts, RK; Seneviratne, E	1
Rampling, A; Sykes, HV; Warren, RE	1
Batts, DH; Browne, RA; Cudmore, MA; Fekety, R; Kim, KH; Silva, J; Toshniwal, R; Wilson, KH	1
Miller, JA; Oldenburger, D	1
Benfiguig, K; Eugène, C; Merrer, J; Mitry, E; Tordjman, R	1
Delmée, M; Melin, P; Peetermans, W; Verbist, L; Verschraegen, G	1
Cartmill, TD; Keith, E; McCann, DC; Nice, CN; Panigrahi, H; Worsley, MA	1
Boss, SM; Francis, PC; Gries, CL; Kirchner, BK; Smith, GD	1
Howe, R; Wilcox, MH	1
Johnson, TR; Pitt, HA; Sciscione, AC; Villeneuve, JB	1
Gröschel, DH	1
Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Mulligan, ME; Surawicz, CM	1
Bailey, EM	1
Claeys, G; De Baere, T; Peleman, R; Steyaert, S; Vaneechoutte, M; Verschraegen, G	1
Danko, L; Elmer, GW; Greenberg, RN; McFarland, LV; Surawicz, CM	1
Jones, RL	1
Aihara, M; Chiba, T; Hajiro, K; Nishi, A; Sakurai, T; Takakuwa, H	1
Chao, L; Nathanson, DR; Sheahan, M; Wallack, MK	1
Gottlieb, T; Leroi, MJ; Siarakas, S	1
Bartlett, JG; Lowe, BR; Onderdonk, AB	1
Finch, RG; George, RH; Lewis, MJ; Slack, RC; Thomas, HJ	1
Bartlett, JG; Chang, TW; Gamble, W; Napier, J; Tedesco, FJ	1
Arabi, Y; Bentley, S; Burdon, DW; George, RH; Johnson, M; Keighley, MR; Mogg, GA; Thompson, H; Williams, JA; Youngs, D	1
Blomberg, S; Möllby, R; Nord, CE; Röjdmark, S	1
Finegold, SM; George, WL; Liechty, EJ; Mok, HY; Richman, DD; Rolfe, RD; Stiner, DB; Volpicelli, NA	1
Crow, J; Larson, HE; Price, AB	1
Burdon, DW; Keighley, M; Mogg, GA	1
Badley, BW; Comeau, SA; Faulkner, RS; Hartlen, MR; Marrie, TJ; Miller, HR	1
Browne, RA; Ebright, JR; Fekety, R; Rifkin, GD; Silva, J	1
Bettin, KM; Clabots, CR; Gerding, DN; Homann, SR; Johnson, S; Peterson, LR; Quick, JN	1
Bárány, P; Bergström, J; Nord, CE; Stenvinkel, P	1
Fruhmann, K; Krotenberg, R; Yablon, SA	1
Buchman, AL; Nagami, PH; Ponsillo, M	1
Chiou, CY; Chiou, HL	1
Powell, KR; Pruksananonda, P	1
de Lalla, F; Ortisi, G; Privitera, G; Rinaldi, E; Rizzardini, G; Santoro, D	1
Berkowitz, I; Sacho, H; Strimling, MO	1
Baird, DR	1
Calver, GP; Hall, SM; Williams, M	1
Barbezat, GO; Cooper, BT; Lee, DK	1
Buggy, B; Deery, HG; Fekety, R; Kauffman, C; Silva, J	1
Coen, LJ; Fernandes, PB; Hanson, CW; Hardy, DJ; Ramer, NR; Shipkowitz, NL; Swanson, RN	1
Panichi, G	1
Kasik, JE	1
Bayley, N; McDonald, MI; St John, DJ; Ward, P; Young, GP	1
Carrington, G; Dudley, MN; Frick, J; McLaughlin, JC; Nightingale, CH; Quintiliani, R	1
Buggy, BP; Fekety, R; Silva, J	1
Abraham, PA; Collins, AJ; Halstenson, CE; Matzke, GR; Olson, PL	1
Bistrian, BR; Blackburn, GL; Tayek, JA	1
Church, JM; Fazio, VW	1
Cuevas, R; Gorbea, HF; Ramírez-Ronda, CH; Sánchez, J	1
Enzensberger, R; Kipp, J; Knothe, H	1
Arsura, EL; Fazio, RA; Wickremesinghe, PC	1
Adams, GL; Griebie, M	1
Lerner, PI	1

Reviews

95 review(s) available for vancomycin and Clostridioides difficile Infection

Article	Year
Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections. Bioorganic & medicinal chemistry, 2019, 08-01, Volume: 27, Issue:15 Topics: Clostridioides difficile; Clostridium Infections; DNA Polymerase III; Drug Discovery; Humans; Microbial Sensitivity Tests; Nucleic Acid Synthesis Inhibitors; Uracil	2019
Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post-2021 Guidelines: Are Economic Barriers Finally Coming Down? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 08-31, Volume: 75, Issue:3 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Hospitals; Humans; Patient Discharge; Vancomycin	2022
Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile. Letters in applied microbiology, 2022, Volume: 75, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Benzimidazoles; Clostridioides; Clostridioides difficile; Clostridium; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Pyridines; Vancomycin	2022
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection. Seminars in respiratory and critical care medicine, 2022, Volume: 43, Issue:1 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Critical Illness; Fecal Microbiota Transplantation; Humans; Vancomycin	2022
How to: Clostridioides difficile infection in children. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:8 Topics: Aged; Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Vancomycin	2022
Probiotics: insights and new opportunities for Critical reviews in microbiology, 2023, Volume: 49, Issue:3 Topics: Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Probiotics; Vancomycin	2023
How can patients with Clostridioides difficile infection on concomitant antibiotic treatment be best managed? The Lancet. Infectious diseases, 2022, Volume: 22, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Vancomycin	2022
Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:11 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Randomized Controlled Trials as Topic; Vancomycin	2022
Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis. European journal of clinical pharmacology, 2022, Volume: 78, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Vancomycin	2022
Path of least recurrence: A systematic review and meta-analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection. Pharmacotherapy, 2022, Volume: 42, Issue:11 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Middle Aged; Recurrence; Vancomycin	2022
Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines. The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Vancomycin	2022
Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis. European journal of pediatrics, 2023, Volume: 182, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Vancomycin	2023
Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy. Pediatrics, 2023, 09-01, Volume: 152, Issue:3 Topics: Adult; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Humans; Vancomycin	2023
Clostridioides difficile infection in the allogeneic hematopoietic cell transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2023, Volume: 25 Suppl 1 Topics: Adult; Anti-Bacterial Agents; Child; Clostridium Infections; Diarrhea; Fidaxomicin; Hematopoietic Stem Cell Transplantation; Humans; Transplant Recipients; Vancomycin	2023
Clinical Guideline Highlights for the Hospitalist: Diagnosis and Management of Clostridium difficile in Adults. Journal of hospital medicine, 2020, 02-01, Volume: 15, Issue:2 Topics: Adult; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Hospitalists; Humans; Practice Guidelines as Topic; Vancomycin	2020
Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Recurrence; Treatment Outcome; Vancomycin	2020
A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent United European gastroenterology journal, 2019, Volume: 7, Issue:8 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Middle Aged; Network Meta-Analysis; Placebos; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Vancomycin	2019
Does oral vancomycin use necessitate therapeutic drug monitoring? Infection, 2020, Volume: 48, Issue:2 Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Monitoring; Humans; Vancomycin	2020
Clostridioides difficile Infection: Update on Management. American family physician, 2020, 02-01, Volume: 101, Issue:3 Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Child; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Infant; Practice Guidelines as Topic; Risk Factors; Severity of Illness Index; Vancomycin	2020
Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020. JAMA, 2020, Apr-14, Volume: 323, Issue:14 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Fidaxomicin; Humans; Nucleic Acid Amplification Techniques; Practice Guidelines as Topic; Vancomycin	2020
Oral vancomycin prophylaxis for the prevention of Infection control and hospital epidemiology, 2020, Volume: 41, Issue:11 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Prospective Studies; Retrospective Studies; Vancomycin	2020
Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability? Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Development; Fidaxomicin; Recurrence; Secondary Prevention; Spores, Bacterial; Vancomycin	2021
Collateral damage during antibiotic treatment of C. difficile infection in the aged host: Insights into why recurrent disease happens. Gut microbes, 2017, 09-03, Volume: 8, Issue:5 Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Immunologic Factors; Mice; Recurrence; Vancomycin	2017
[Individualized treatment strategies for Clostridium difficile infections]. Der Internist, 2017, Volume: 58, Issue:7 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Metronidazole; Recurrence; Secondary Prevention; Vancomycin	2017
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:5 Topics: Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fecal Microbiota Transplantation; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin	2017
Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin? Expert review of clinical pharmacology, 2017, Volume: 10, Issue:11 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Design; Humans; Metronidazole; Practice Guidelines as Topic; Recurrence; Severity of Illness Index; Vancomycin	2017
Management of inflammatory bowel disease with World journal of gastroenterology, 2017, Jul-21, Volume: 23, Issue:27 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Immunosuppression Therapy; Incidence; Inflammatory Bowel Diseases; Risk Factors; Symptom Flare Up; Vancomycin	2017
Bezlotoxumab for the prevention of Clostridium difficile recurrence. Expert opinion on biological therapy, 2017, Volume: 17, Issue:11 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Bacterial Proteins; Bacterial Toxins; Broadly Neutralizing Antibodies; Clinical Trials as Topic; Clostridium Infections; Half-Life; Humans; Recurrence; Vancomycin	2017
A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection. PharmacoEconomics, 2017, Volume: 35, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; Hospitalization; Humans; Metronidazole; Recurrence; Vancomycin	2017
New and emerging therapies in treatment of Clostridium difficile infection. European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:6 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin; Vancomycin Resistance	2018
[Treatment of acute and recurrent Clostridium difficile infections : What is new?] Der Internist, 2018, Volume: 59, Issue:5 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Germany; Humans; Vancomycin	2018
Clinical medicine (London, England), 2018, Volume: 18, Issue:3 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Metronidazole; Probiotics; Vancomycin	2018
Antibiotic Treatment for Clostridium difficile Infection in Adults. The American journal of nursing, 2018, Volume: 118, Issue:7 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Vancomycin	2018
Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting. Infection control and hospital epidemiology, 2018, Volume: 39, Issue:8 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Fidaxomicin; Health Care Costs; Humans; Monte Carlo Method; Quality-Adjusted Life Years; Recurrence; Vancomycin	2018
Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:11 Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Randomized Controlled Trials as Topic; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin	2018
Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infection. The Annals of pharmacotherapy, 2019, Volume: 53, Issue:4 Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Secondary Prevention; Vancomycin	2019
Vancomycin Versus Metronidazole for Nonsevere The Annals of pharmacotherapy, 2019, Volume: 53, Issue:8 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Guidelines as Topic; Humans; Metronidazole; Treatment Outcome; Vancomycin	2019
Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease. Advances in chronic kidney disease, 2019, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antimicrobial Stewardship; Broadly Neutralizing Antibodies; Clostridium Infections; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Hand Hygiene; Health Care Costs; Humans; Infection Control; Kidney Failure, Chronic; Length of Stay; Metronidazole; Patient Isolation; Renal Insufficiency, Chronic; Secondary Prevention; Vancomycin	2019
Surotomycin (A Novel Cyclic Lipopeptide) vs. Vancomycin for the Treatment of Clostridioides difficile Infection: A Systematic Review and Meta-analysis. Current clinical pharmacology, 2019, Volume: 14, Issue:3 Topics: Bias; Clostridium Infections; Humans; Lipopeptides; Peptides, Cyclic; Vancomycin	2019
Clostridium difficile Infection in Children. Advances in pediatrics, 2019, Volume: 66 Topics: Age Factors; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Humans; Incidence; Male; Metronidazole; Prognosis; Risk Assessment; Sex Factors; United States; Vancomycin	2019
Cadazolid vs Vancomycin for the Treatment of Clostridioides difficile Infection: Systematic Review with Meta-analysis. Current clinical pharmacology, 2020, Volume: 15, Issue:1 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Oxazolidinones; Randomized Controlled Trials as Topic; Vancomycin	2020
Diagnosis and management of Clostridium difficile infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, Volume: 11, Issue:10 Topics: Administration, Oral; Aminoglycosides; Anti-Infective Agents; Biological Therapy; Clostridioides difficile; Clostridium Infections; Colectomy; False Positive Reactions; Fidaxomicin; Humans; Immunotherapy; Metronidazole; Molecular Diagnostic Techniques; Vancomycin	2013
Treatment of recurrent Clostridium difficile infection: a systematic review. Infection, 2014, Volume: 42, Issue:1 Topics: Anti-Infective Agents; Biological Therapy; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Humans; Metronidazole; Secondary Prevention; Treatment Outcome; Vancomycin	2014
[Clostridium difficile infection: epidemiology, disease burden and therapy]. Orvosi hetilap, 2013, Jul-28, Volume: 154, Issue:30 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cost of Illness; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Health Care Costs; Humans; Hungary; Metronidazole; Public Health; Recurrence; Seasons; Vancomycin	2013
Clostridium difficile infection in the elderly. Clinics in geriatric medicine, 2014, Volume: 30, Issue:1 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Management; Humans; Metronidazole; Outcome Assessment, Health Care; Prevalence; Risk Factors; Severity of Illness Index; Vancomycin	2014
[Clostridium difficile infecion--diagnostics, prevention and treatment]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2014, Volume: 36, Issue:214 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Feces; Fidaxomicin; Humans; Metronidazole; Probiotics; Secondary Prevention; Vancomycin	2014
[Gastrointestinal infections]. Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:25-26 Topics: Adult; Anti-Bacterial Agents; Clostridium Infections; Colitis; Diagnosis, Differential; Female; Humans; Prednisone; Treatment Outcome; Vancomycin	2014
Clostridium difficile infection in patients with ileal pouches. The American journal of gastroenterology, 2014, Volume: 109, Issue:7 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonic Pouches; Endoscopy; Humans; Postoperative Complications; Proctocolectomy, Restorative; Risk Factors; Sex Factors; Vancomycin	2014
Challenges and opportunities in the management of Clostridium difficile infection. Expert review of gastroenterology & hepatology, 2014, Volume: 8, Issue:8 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Immunologic Factors; Metronidazole; Probiotics; Vancomycin	2014
Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin	2014
Intracolonic administration of vancomycin for Clostridium difficile infection. Nursing, 2014, Volume: 44, Issue:9 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colon; Evidence-Based Practice; Humans; Practice Guidelines as Topic; Vancomycin	2014
Treatment of Clostridium difficile infections. Infectious disease clinics of North America, 2015, Volume: 29, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin	2015
Luminal Toxin-Binding Agents for Clostridium difficile Infection. Journal of pharmacy practice, 2016, Volume: 29, Issue:4 Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Clostridium Infections; Humans; Metronidazole; Toxins, Biological; Vancomycin	2016
Current advances related to Clostridium difficile infection. The Indian journal of medical research, 2015, Volume: 141, Issue:2 Topics: Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Humans; Immunity, Cellular; Metronidazole; Risk Factors; Vancomycin	2015
Fidaxomicin--the new drug for Clostridium difficile infection. The Indian journal of medical research, 2015, Volume: 141, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Recurrence; Vancomycin	2015
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options. Drugs & aging, 2015, Volume: 32, Issue:8 Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin	2015
Clostridium difficile infection in patients with liver disease: a review. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:12 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diagnostic Tests, Routine; Diarrhea; Drug Therapy, Combination; Humans; Liver Cirrhosis; Liver Transplantation; Metronidazole; Treatment Outcome; Vancomycin	2015
The Surgical Management of Complicated Clostridium Difficile Infection: Alternatives to Colectomy. Surgical infections, 2016, Volume: 17, Issue:3 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Combined Modality Therapy; Cross Infection; Enema; Humans; Ileostomy; Therapeutic Irrigation; Vancomycin	2016
[Oncologic aspects of Clostridium difficile]. Orvosi hetilap, 2016, Volume: 157, Issue:28 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Gastrointestinal Microbiome; Humans; Recurrence; Risk Factors; Vancomycin	2016
Clostridium difficile infection. Clinical medicine (London, England), 2008, Volume: 8, Issue:5 Topics: Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Risk Factors; Treatment Failure; Vancomycin	2008
Clostridium difficile infection: current perspectives. Current opinion in critical care, 2009, Volume: 15, Issue:2 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Intensive Care Units; Proton Pump Inhibitors; Secondary Prevention; Severity of Illness Index; United States; Vancomycin; Virulence Factors	2009
Clostridium difficile: controversies and approaches to management. Current opinion in infectious diseases, 2009, Volume: 22, Issue:6 Topics: Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Humans; Immunization, Passive; Metronidazole; Probiotics; Vancomycin	2009
Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:2 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Glycosides; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin	2010
Best strategies in recurrent or persistent Clostridium difficile infection. Surgical infections, 2011, Volume: 12, Issue:3 Topics: Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Humans; Metronidazole; Probiotics; Secondary Prevention; Vancomycin	2011
Fidaxomicin: first-in-class macrocyclic antibiotic. Expert review of anti-infective therapy, 2011, Volume: 9, Issue:7 Topics: Actinomycetales; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Cross Infection; DNA-Directed RNA Polymerases; Fidaxomicin; Gastrointestinal Tract; Humans; Microbial Sensitivity Tests; Nucleic Acid Synthesis Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin	2011
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature. Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:3 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Humans; Metronidazole; Minocycline; Recurrence; Rifamycins; Rifaximin; Tigecycline; Treatment Outcome; Vancomycin	2012
Clostridium difficile infection: clinical spectrum and approach to management. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2011, Volume: 30, Issue:6 Topics: Aminoglycosides; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Dietary Supplements; Digestive System Surgical Procedures; Disease Management; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Routes; Fidaxomicin; Humans; Ileus; Immunoglobulins, Intravenous; Inflammatory Bowel Diseases; Metronidazole; Severity of Illness Index; Vancomycin; Withholding Treatment	2011
Comparative effectiveness of Clostridium difficile treatments: a systematic review. Annals of internal medicine, 2011, Dec-20, Volume: 155, Issue:12 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Comparative Effectiveness Research; Diarrhea; Drug Therapy, Combination; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin	2011
Clostridium difficile infection in older adults: a review and update on its management. The American journal of geriatric pharmacotherapy, 2012, Volume: 10, Issue:1 Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Infection Control; Metronidazole; Risk Factors; Vancomycin	2012
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. International journal of antimicrobial agents, 2012, Volume: 40, Issue:1 Topics: Anti-Bacterial Agents; Asia; Clostridioides difficile; Clostridium Infections; Europe; Humans; Metronidazole; North America; Recurrence; Treatment Failure; Vancomycin	2012
Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, Jun-01, Volume: 69, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Microbial Sensitivity Tests; Severity of Illness Index; Vancomycin	2012
Safety analysis of fidaxomicin in comparison with oral vancomycin for Clostridium difficile infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Diarrhea; Dogs; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Fidaxomicin; Humans; Treatment Outcome; Vancomycin	2012
Current state of Clostridium difficile treatment options. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fusidic Acid; Humans; Metronidazole; Nitro Compounds; Secondary Prevention; Severity of Illness Index; Teicoplanin; Thiazoles; Treatment Outcome; Vancomycin	2012
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Eosinophils; Feces; Fidaxomicin; Humans; Intention to Treat Analysis; Leukocyte Count; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Vancomycin	2012
Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18 Suppl 6 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Recurrence; Vancomycin	2012
Clostridium difficile infection: new insights into management. Mayo Clinic proceedings, 2012, Volume: 87, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Clostridium Infections; Diarrhea; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Vancomycin	2012
Clostridium difficile infection--an unusual cause of refractory pouchitis: report of a case. Diseases of the colon and rectum, 2003, Volume: 46, Issue:2 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonic Pouches; Female; Humans; Ileum; Pouchitis; Proctocolectomy, Restorative; Treatment Outcome; Vancomycin	2003
Alternative treatments for Clostridium difficile disease: what really works? Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 2 Topics: Anti-Infective Agents; Carrier State; Clostridioides difficile; Clostridium Infections; Colitis; Complementary Therapies; Cross Infection; Humans; Metronidazole; Vancomycin	2005
Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea? The Journal of family practice, 2005, Volume: 54, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Humans; Metronidazole; Vancomycin	2005
Clinical manifestations, treatment and control of infections caused by Clostridium difficile. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11 Suppl 4 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Vancomycin	2005
Antimicrobial therapy of Clostridium difficile-associated diarrhea. The Medical clinics of North America, 2006, Volume: 90, Issue:6 Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Infant; Megacolon, Toxic; Metronidazole; Nitro Compounds; Risk Factors; Secondary Prevention; Thiazoles; Vancomycin	2006
Clostridium difficile-associated disease: changing epidemiology and implications for management. Drugs, 2007, Volume: 67, Issue:4 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Risk Factors; Vancomycin	2007
Clostridium difficile: dealing with a silent menace. British journal of community nursing, 2007, Volume: 12, Issue:7 Topics: Anti-Bacterial Agents; Antidiarrheals; Clostridioides difficile; Clostridium Infections; Disinfection; Drug Prescriptions; Early Diagnosis; Humans; Incidence; Infection Control; Population Surveillance; Primary Prevention; Recurrence; Risk Factors; United Kingdom; Vancomycin	2007
Current and future treatment modalities for Clostridium difficile-associated disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Apr-15, Volume: 65, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Vaccines; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin	2008
Clostridium difficile colitis. Advances in internal medicine, 1984, Volume: 29 Topics: Adult; Animals; Anti-Bacterial Agents; Carrier State; Child; Clostridium; Clostridium Infections; Colitis; Colitis, Ulcerative; Cricetinae; Crohn Disease; Cross Infection; Cytotoxins; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Infant; Infant, Newborn; Vancomycin	1984
Antibiotic-associated colitis. Disease-a-month : DM, 1984, Volume: 30, Issue:15 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Colitis; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Fluid Therapy; Humans; Metronidazole; Recurrence; Staphylococcal Infections; Vancomycin	1984
[Pseudomembranous colitis. Aetiology, clinic and treatment (author's transl)]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1982, Jan-19, Volume: 71, Issue:3 Topics: Cholestyramine Resin; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Gastrointestinal Diseases; Humans; Ischemia; Lincomycin; Metals; Staphylococcal Infections; Tetracycline; Vancomycin	1982
Pseudomembranous colitis. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1982, Jan-19, Volume: 71, Issue:3 Topics: Anion Exchange Resins; Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Feces; Humans; Intestinal Mucosa; Leukocytes; Lincomycin; Metronidazole; Vancomycin	1982
Pseudomembranous colitis: pathogenesis and therapy. The Medical clinics of North America, 1982, Volume: 66, Issue:3 Topics: Anti-Bacterial Agents; Atropine; Bacitracin; Botulinum Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Colestipol; Diphenoxylate; Drug Combinations; Enterocolitis, Pseudomembranous; Gastrointestinal Agents; Humans; Intestinal Mucosa; Metronidazole; Vancomycin	1982
Surgery for pancreatic tumors during pregnancy: a case report and review of the literature. American journal of perinatology, 1996, Volume: 13, Issue:1 Topics: Adult; Anti-Bacterial Agents; Cerebral Hemorrhage; Cesarean Section; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fetal Distress; Fluid Therapy; Humans; Infant, Newborn; Pancreatic Neoplasms; Postoperative Complications; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Risk Factors; Vancomycin	1996
Clostridium difficile infection. Critical reviews in clinical laboratory sciences, 1996, Volume: 33, Issue:3 Topics: Antitrichomonal Agents; Bacterial Proteins; Bacterial Toxins; Cells, Cultured; Clostridioides difficile; Clostridium Infections; Disease Transmission, Infectious; Enterotoxins; Feces; Glutamate Dehydrogenase; Humans; Immunoassay; Metronidazole; Polymerase Chain Reaction; Risk Factors; Vancomycin	1996
Treatment of Clostridium difficile-associated diarrhea and colitis. Current topics in microbiology and immunology, 2000, Volume: 250 Topics: Abdomen, Acute; Anti-Bacterial Agents; Antidiarrheals; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Colectomy; Colitis; Combined Modality Therapy; Contraindications; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Intestinal Perforation; Megacolon, Toxic; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin	2000
Clostridial enterocolitis. The Veterinary clinics of North America. Equine practice, 2000, Volume: 16, Issue:3 Topics: Animals; Bacitracin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Disease Outbreaks; Enterocolitis, Pseudomembranous; Horse Diseases; Horses; Metronidazole; Vancomycin	2000
Antibiotic-associated colitis. Clinics in gastroenterology, 1979, Volume: 8, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Culture Techniques; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	1979
Vancomycin: specialized niche for a narrow-spectrum antibiotic. Iowa medicine : journal of the Iowa Medical Society, 1988, Volume: 78, Issue:6 Topics: Clostridium Infections; Humans; Staphylococcal Infections; Streptococcal Infections; Vancomycin	1988

Trials

63 trial(s) available for vancomycin and Clostridioides difficile Infection

Article	Year
OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Anti-Bacterial Agents; Bacteroides; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Glycosides; Humans; Vancomycin	2009
Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycosides; Humans; Male; Middle Aged; Treatment Outcome	2009
Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence. Contemporary clinical trials, 2022, Volume: 116 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; COVID-19; Diarrhea; Fidaxomicin; Humans; Recurrence; Treatment Outcome; Vancomycin	2022
High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Bacteria; Cholecalciferol; Clostridioides difficile; Clostridium Infections; Dietary Supplements; Gastrointestinal Microbiome; Humans; Prospective Studies; RNA, Ribosomal, 16S; Vancomycin; Vitamin D; Vitamin D Deficiency	2022
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial. The lancet. Gastroenterology & hepatology, 2022, Volume: 7, Issue:12 Topics: Clostridium Infections; Diarrhea; Double-Blind Method; Fecal Microbiota Transplantation; Humans; Vancomycin	2022
Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of BMJ open, 2023, 09-13, Volume: 13, Issue:9 Topics: Adult; Anti-Bacterial Agents; Clostridium Infections; Hospitals, University; Humans; Secondary Prevention; Vancomycin	2023
Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 08-22, Volume: 71, Issue:5 Topics: Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Delivery of Health Care; Humans; North Carolina; Retrospective Studies; Vancomycin	2020
Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-17, Volume: 71, Issue:10 Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides; Clostridioides difficile; Clostridium; Clostridium Infections; Fidaxomicin; Humans; Single-Blind Method; Treatment Outcome; Vancomycin	2020
Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:9 Topics: Clostridioides; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Feces; Humans; Recurrence; Treatment Outcome; Vancomycin	2021
Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 03-01, Volume: 74, Issue:4 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Prospective Studies; Vancomycin	2022
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. The Lancet. Infectious diseases, 2017, Volume: 17, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Canada; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Feces; Female; Humans; Male; Middle Aged; Treatment Outcome; United States; Vancomycin	2017
Bacteriophage transfer during faecal microbiota transplantation in Gut, 2018, Volume: 67, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriophages; Case-Control Studies; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Male; Middle Aged; Treatment Outcome; Vancomycin	2018
Polyethylene glycol intestinal lavage in addition to usual antibiotic treatment for severe BMJ open, 2017, Jul-31, Volume: 7, Issue:7 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Therapeutic Irrigation; Vancomycin	2017
Enteric microbiome profiles during a randomized Phase 2 clinical trial of surotomycin versus vancomycin for the treatment of Clostridium difficile infection. The Journal of antimicrobial chemotherapy, 2017, Dec-01, Volume: 72, Issue:12 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Load; Bacteriological Techniques; Clostridium Infections; Double-Blind Method; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Humans; Lipopeptides; Male; Metagenomics; Middle Aged; Peptides, Cyclic; Real-Time Polymerase Chain Reaction; Time Factors; Vancomycin; Young Adult	2017
Surotomycin versus vancomycin in adults with Clostridium difficile infection: primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trial. The Journal of antimicrobial chemotherapy, 2017, Dec-01, Volume: 72, Issue:12 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Double-Blind Method; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Placebos; Treatment Outcome; Vancomycin; Young Adult	2017
The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:2 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Japan; Male; Metronidazole; Placebos; Recurrence; Time Factors; Vancomycin	2018
Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 01-18, Volume: 66, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cost-Benefit Analysis; Female; Humans; Male; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Recurrence; Secondary Prevention; Vancomycin	2018
Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome. PloS one, 2017, Volume: 12, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Bacteria; Biodiversity; Clostridium Infections; Demography; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Genotype; Humans; Male; Metagenomics; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Principal Component Analysis; RNA, Ribosomal, 16S; Species Specificity; Tissue Donors; Vancomycin; Young Adult	2017
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 08-16, Volume: 67, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Risk Factors; Secondary Prevention; Vancomycin; Young Adult	2018
Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin. The Journal of antimicrobial chemotherapy, 2018, 08-01, Volume: 73, Issue:8 Topics: Anti-Bacterial Agents; Benzimidazoles; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Pyridines; Ribotyping; Vancomycin	2018
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness. The Journal of antimicrobial chemotherapy, 2018, 09-01, Volume: 73, Issue:9 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; England; Female; Fidaxomicin; Humans; Male; Middle Aged; Quality of Life; Recurrence; Treatment Outcome; Vancomycin	2018
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Alimentary pharmacology & therapeutics, 2018, Volume: 48, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonoscopy; Combined Modality Therapy; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Feces; Female; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Vancomycin	2018
Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Fidaxomicin; Hospitalization; Humans; Japan; Male; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome; Vancomycin; Young Adult	2018
Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin. PloS one, 2018, Volume: 13, Issue:8 Topics: Actinobacteria; Anti-Bacterial Agents; Benzimidazoles; Clostridioides difficile; Clostridium Infections; Cohort Studies; Discriminant Analysis; DNA, Bacterial; Feces; Firmicutes; Gastrointestinal Microbiome; Humans; Principal Component Analysis; Proteobacteria; Pyridines; Vancomycin	2018
Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Gut, 2019, Volume: 68, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Female; Humans; Male; Metronidazole; Middle Aged; Rifaximin; Secondary Prevention; Vancomycin	2019
Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak. Medecine et maladies infectieuses, 2019, Volume: 49, Issue:3 Topics: Aged; Aged, 80 and over; Antibiosis; Clostridium Infections; Disease Eradication; Disease Outbreaks; Dysbiosis; Fecal Microbiota Transplantation; Female; Follow-Up Studies; France; Gram-Positive Bacterial Infections; Humans; Intestines; Male; Middle Aged; Pilot Projects; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci	2019
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Gastroenterology, 2019, Volume: 156, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Denmark; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Male; Middle Aged; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Vancomycin; Young Adult	2019
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Fidaxomicin; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Ribotyping; Treatment Outcome; Vancomycin	2019
Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile. The Journal of infectious diseases, 2014, May-01, Volume: 209, Issue:9 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Double-Blind Method; Drug Resistance, Bacterial; Fidaxomicin; Genome, Bacterial; Humans; Polymorphism, Single Nucleotide; Secondary Prevention; Sequence Analysis, DNA; Vancomycin	2014
Risk estimation for recurrent Clostridium difficile infection based on clinical factors. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:10 Topics: Adult; Age Factors; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Creatine; Female; Fidaxomicin; Humans; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Recurrence; Risk Factors; Vancomycin; Young Adult	2014
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Polymers; Recurrence; Sulfonic Acids; Vancomycin; Young Adult	2014
Pharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Middle Aged; Thiazoles; Vancomycin	2015
Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Middle Aged; Thiazoles; Vancomycin	2015
Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin. The Journal of hospital infection, 2015, Volume: 90, Issue:3 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Environmental Microbiology; Female; Fidaxomicin; Hospitalization; Humans; Male; Metronidazole; Vancomycin	2015
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Alimentary pharmacology & therapeutics, 2015, Volume: 41, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Microbiota; Middle Aged; Treatment Outcome; Vancomycin	2015
Differences of the Fecal Microflora With Clostridium difficile Therapies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, May-15, Volume: 60 Suppl 2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Load; Bacteroidetes; Clostridioides difficile; Clostridium Infections; Feces; Female; Gastrointestinal Microbiome; Humans; Lactobacillus; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Polymers; Probiotics; Sulfonic Acids; Time Factors; Treatment Outcome; Vancomycin	2015
Impact of vancomycin faecal concentrations on clinical and microbiological outcomes in Clostridium difficile infection. International journal of antimicrobial agents, 2015, Volume: 46, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Middle Aged; Time Factors; Treatment Outcome; Vancomycin	2015
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazolidinones; Patient Safety; Recurrence; Vancomycin	2015
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Ribotyping; Vancomycin; Young Adult	2016
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Recurrence; Treatment Outcome; Vancomycin	2016
Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infection control and hospital epidemiology, 2010, Volume: 31, Issue:1 Topics: Aged; Aged, 80 and over; Bacterial Typing Techniques; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Environmental Microbiology; Feces; Female; Hospital Units; Humans; Male; Metronidazole; Middle Aged; Ribotyping; Skin; Spores, Bacterial; Treatment Outcome; Vancomycin	2010
Treatment with monoclonal antibodies against Clostridium difficile toxins. The New England journal of medicine, 2010, Jan-21, Volume: 362, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal; Antitoxins; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Male; Metronidazole; Middle Aged; Secondary Prevention; Vancomycin; Young Adult	2010
A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiology (Reading, England), 2010, Volume: 156, Issue:Pt 11 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; DNA, Bacterial; Feces; Fidaxomicin; Humans; Intestines; Metagenome; Phylogeny; Vancomycin	2010
Fidaxomicin versus vancomycin for Clostridium difficile infection. The New England journal of medicine, 2011, Feb-03, Volume: 364, Issue:5 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Humans; Intention to Treat Analysis; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Secondary Prevention; Treatment Outcome; Vancomycin	2011
Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Fidaxomicin; Humans; Male; Middle Aged; Molecular Typing; Polymorphism, Restriction Fragment Length; Prohibitins; Recurrence; Treatment Outcome; Vancomycin	2012
Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies. Future microbiology, 2012, Volume: 7, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Female; Fidaxomicin; Humans; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Vancomycin	2012
Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Canada; Clostridioides difficile; Clostridium Infections; Diarrhea; DNA, Bacterial; Enterotoxins; Europe; Feces; Fidaxomicin; Humans; Middle Aged; Prohibitins; Secondary Prevention; Time Factors; United States; Vancomycin	2012
Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Administration, Oral; Aged; Aminoglycosides; Anti-Bacterial Agents; Chromatography, Liquid; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Feces; Female; Fidaxomicin; Humans; Male; Middle Aged; Severity of Illness Index; Tandem Mass Spectrometry; Treatment Outcome; Vancomycin	2012
Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Canada; Candida; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Drug Resistance, Bacterial; Enterococcus; Feces; Female; Fidaxomicin; Humans; Incidence; Limit of Detection; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; United States; Vancomycin	2012
Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cytotoxins; DNA, Bacterial; Double-Blind Method; Feces; Fidaxomicin; Gene Expression Regulation, Bacterial; Humans; Intestines; Limit of Detection; Metagenome; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; Secondary Prevention; Vancomycin	2012
Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Canada; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Double-Blind Method; Europe; Feces; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Secondary Prevention; Time Factors; Treatment Outcome; United States; Vancomycin; Young Adult	2012
Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients. Inflammatory bowel diseases, 2013, Volume: 19, Issue:2 Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Feces; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Postoperative Complications; Pouchitis; Proctocolectomy, Restorative; Prospective Studies; Recurrence; Risk Factors; Treatment Outcome; Vancomycin	2013
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet (London, England), 1983, Nov-05, Volume: 2, Issue:8358 Topics: Adult; Aged; Clinical Trials as Topic; Clostridium Infections; Colitis; Costs and Cost Analysis; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Random Allocation; Vancomycin	1983
Therapeutic trials of antibiotic associated colitis. Scandinavian journal of infectious diseases. Supplementum, 1980, Issue:Suppl 22 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clinical Trials as Topic; Clostridium; Clostridium Infections; Colestipol; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Humans; Polyamines; Vancomycin	1980
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Risk Factors; Seasons; Vancomycin	1997
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cells, Cultured; Clostridium Infections; Feces; Humans; Metronidazole; Placebos; Recurrence; Saccharomyces; Time Factors; Vancomycin	1999
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. British medical journal, 1978, Dec-16, Volume: 2, Issue:6153 Topics: Bacterial Toxins; Clinical Trials as Topic; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Postoperative Complications; Random Allocation; Vancomycin	1978
Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Annals of internal medicine, 1992, Aug-15, Volume: 117, Issue:4 Topics: Aged; Bacterial Typing Techniques; Carrier State; Clostridioides difficile; Clostridium Infections; Cross Infection; DNA Restriction Enzymes; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Prohibitins; Vancomycin	1992
Treatment of Clostridium difficile-associated disease with teicoplanin. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:7 Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cytotoxins; Diarrhea; Female; Glycopeptides; Humans; Male; Microbial Sensitivity Tests; Teicoplanin; Vancomycin	1989
Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. The American journal of medicine, 1989, Volume: 86, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clostridium; Clostridium Infections; Colitis; Diarrhea; Humans; Infant; Middle Aged; Vancomycin	1989
Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors. The Medical journal of Australia, 1986, Mar-17, Volume: 144, Issue:6 Topics: Aged; Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Colitis; Feces; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Recurrence; Risk; Vancomycin	1986
Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. Archives of internal medicine, 1986, Volume: 146, Issue:6 Topics: Aged; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Middle Aged; Random Allocation; Recurrence; Time Factors; Vancomycin	1986
Treatment of Clostridium difficile colitis. Gastroenterology, 1985, Volume: 89, Issue:5 Topics: Animals; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Random Allocation; Vancomycin	1985

Other Studies

420 other study(ies) available for vancomycin and Clostridioides difficile Infection

Article	Year
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Quebec; Ribotyping; Risk Factors	2008
Antibacterial and Solubility Optimization of Thiomuracin A. Journal of medicinal chemistry, 2016, 07-28, Volume: 59, Issue:14 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Peptides, Cyclic; Solubility; Structure-Activity Relationship; Thiazoles	2016
Facilely accessible quinoline derivatives as potent antibacterial agents. Bioorganic & medicinal chemistry, 2018, 07-23, Volume: 26, Issue:12 Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship	2018
Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB). Bioorganic & medicinal chemistry letters, 2018, 12-15, Volume: 28, Issue:23-24 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Benzodiazepines; CHO Cells; Clostridioides difficile; Clostridium Infections; Cricetinae; Cricetulus; Half-Life; Mice; Structure-Activity Relationship	2018
Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model. European journal of medicinal chemistry, 2019, May-15, Volume: 170 Topics: Animals; Anti-Bacterial Agents; Cations; Clostridioides difficile; Clostridium Infections; Humans; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Peptidomimetics; Triazoles	2019
Salicylanilide Analog Minimizes Relapse of Journal of medicinal chemistry, 2020, 07-09, Volume: 63, Issue:13 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Male; Mice; Mice, Inbred C57BL; Recurrence; Safety; Salicylanilides; Tissue Distribution	2020
Outcomes of clinical decision support for outpatient management of Infection control and hospital epidemiology, 2022, Volume: 43, Issue:10 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Decision Support Systems, Clinical; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Outpatients; Vancomycin	2022
Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection. Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2 Topics: Aged; Aged, 80 and over; Bacteriological Techniques; Clostridioides; Clostridioides difficile; Clostridium Infections; Diagnostic Tests, Routine; Diarrhea; Feces; Female; Humans; Immunoenzyme Techniques; Male; Metronidazole; Middle Aged; Multivariate Analysis; Treatment Outcome; Vancomycin	2021
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27 Suppl 2 Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Practice Guidelines as Topic; Recurrence; Societies, Medical; Vancomycin	2021
A case of vasculitis triggered by infective endocarditis in a patient undergoing maintenance hemodialysis: a case report. BMC nephrology, 2022, 01-03, Volume: 23, Issue:1 Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Echocardiography, Transesophageal; Endocarditis; Glucocorticoids; Humans; IgA Vasculitis; Kidney Failure, Chronic; Male; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Prednisolone; Renal Dialysis; Staphylococcal Infections; Vancomycin	2022
Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant. Transplant infectious disease : an official journal of the Transplantation Society, 2022, Volume: 24, Issue:2 Topics: Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies; Vancomycin	2022
Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 01-07, Volume: 74, Issue:1 Topics: Animals; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Kenya; Mice; Vancomycin	2022
Association between prevalence of laboratory-identified Infection control and hospital epidemiology, 2022, Volume: 43, Issue:12 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Hospitals; Humans; Prevalence; Vancomycin	2022
Non-inferiority of metronidazole to vancomycin in the treatment of first episode non-severe Clostridioides difficile infection: a single center retrospective cohort study. Infection, 2022, Volume: 50, Issue:4 Topics: Adult; Aftercare; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Hospital Mortality; Humans; Infant, Newborn; Metronidazole; Patient Discharge; Recurrence; Retrospective Studies; Vancomycin	2022
Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model. Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bifidobacterium breve; Clostridioides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Feces; Metronidazole; Mice; RNA, Ribosomal, 16S; Vancomycin	2022
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study. The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridium Infections; Cohort Studies; Fidaxomicin; Humans; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin	2022
Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile. Zoonoses and public health, 2022, Volume: 69, Issue:6 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Dog Diseases; Dogs; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tetracyclines; Vancomycin	2022
Houston, We Have a Problem: Reports of Clostridioides difficile Isolates With Reduced Vancomycin Susceptibility. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-29, Volume: 75, Issue:9 Topics: Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Vancomycin	2022
Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients. European journal of cancer (Oxford, England : 1990), 2022, Volume: 171 Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Neoplasms; Recurrence; Retrospective Studies; Vancomycin	2022
Are Vancomycin Non-Susceptible Clostridioides difficile Strains Emerging? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-29, Volume: 75, Issue:9 Topics: Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Vancomycin	2022
Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection. Antimicrobial agents and chemotherapy, 2022, 08-16, Volume: 66, Issue:8 Topics: Actinobacteria; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides difficile; Clostridium Infections; Humans; Vancomycin	2022
Efficacy of Omadacycline or Vancomycin Combined With Germinants for Preventing Clostridioides difficile Relapse in a Murine Model. The Journal of infectious diseases, 2023, 03-01, Volume: 227, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Mice; Recurrence; Vancomycin; Weight Loss	2023
The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model. Applied microbiology and biotechnology, 2022, Volume: 106, Issue:19-20 Topics: Animals; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Granulocyte Colony-Stimulating Factor; Inflammation Mediators; Interleukin-6; Mice; Raffinose; Recurrence; Treatment Outcome; Tryptophan; Tumor Necrosis Factor-alpha; Valine; Vancomycin	2022
Fidaxomicin-Associated Hypersensitivity Reactions: Report of a Morbilliform Drug Eruption. Journal of pharmacy practice, 2023, Volume: 36, Issue:4 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Eruptions; Exanthema; Female; Fidaxomicin; Humans; Hypersensitivity; Middle Aged; Pharmaceutical Preparations; Vancomycin	2023
Oral fidaxomicin versus vancomycin for Clostridioides difficile infection. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2022, Volume: 29, Issue:12 Topics: Anti-Bacterial Agents; Clostridium Infections; Fidaxomicin; Humans; Vancomycin	2022
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 03-04, Volume: 76, Issue:5 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Genomics; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; United States; Vancomycin	2023
[Clostridioides difficile infection: various therapeutic approaches]. Revue medicale suisse, 2022, Oct-12, Volume: 18, Issue:799 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Vancomycin	2022
Impact of a change in universal gloving protocol on rates of central line-related bloodstream infection, Clostridioides difficile, and vancomycin-resistant Enterococcus. American journal of infection control, 2023, Volume: 51, Issue:6 Topics: Adult; Clostridioides; Clostridium Infections; Cross Infection; Humans; Infection Control; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci	2023
Intravenous metronidazole for fulminant Clostridioides difficile infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:5 Topics: Anti-Bacterial Agents; Clostridium Infections; Humans; Metronidazole; Vancomycin	2023
Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance. The Journal of antimicrobial chemotherapy, 2023, 04-03, Volume: 78, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Fidaxomicin; Humans; Hypersensitivity; Macrolides; Vancomycin	2023
Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent The New England journal of medicine, 2023, 02-16, Volume: 388, Issue:7 Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Recurrence; Secondary Prevention; Vancomycin	2023
[Updated Czech guidelines for the treatment of patients with colitis due to Clostridioides difficile]. Klinicka mikrobiologie a infekcni lekarstvi, 2022, Volume: 28, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Colitis; Czech Republic; Fidaxomicin; Humans; Tigecycline; Vancomycin	2022
A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital. Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo, 2023, Volume: 41 Topics: Anti-Bacterial Agents; Asparaginase; Busulfan; Cancer Care Facilities; Carboplatin; Case-Control Studies; Cefepime; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Humans; Melphalan; Meropenem; Neoplasms; Retrospective Studies; Risk Factors; Vancomycin	2023
The natural product chlorotonil A preserves colonization resistance and prevents relapsing Clostridioides difficile infection. Cell host & microbe, 2023, 05-10, Volume: 31, Issue:5 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Mice; Swine; Vancomycin	2023
Live fecal microbiota oral capsules (Vowst) for prevention of CDI recurrence. The Medical letter on drugs and therapeutics, 2023, 05-29, Volume: 65, Issue:1677 Topics: Anti-Bacterial Agents; Capsules; Clostridium Infections; Humans; Microbiota; Recurrence; Vancomycin	2023
[Clostridioides difficile - New Insights and Therapy Recommendations]. Deutsche medizinische Wochenschrift (1946), 2023, Volume: 148, Issue:12 Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Vancomycin	2023
Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease. Journal of gastroenterology and hepatology, 2023, Volume: 38, Issue:11 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Humans; Inflammatory Bowel Diseases; Male; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin	2023
Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients. Clinical transplantation, 2023, Volume: 37, Issue:9 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Primary Prevention; Retrospective Studies; Vancomycin	2023
International journal of molecular sciences, 2023, Sep-27, Volume: 24, Issue:19 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Fecal Microbiota Transplantation; Feces; Humans; Mice; Recurrence; Treatment Outcome; Vancomycin	2023
Risk factors for Recurrent Clostridioides Difficile Infection in Children. Hospital pediatrics, 2023, 11-01, Volume: 13, Issue:11 Topics: Anti-Bacterial Agents; Child; Chronic Disease; Clostridioides difficile; Clostridium Infections; Female; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin	2023
Look What the Cat Dragged in! Recurrent Clostridioides difficile from a Household Cat. The American journal of case reports, 2023, Oct-27, Volume: 24 Topics: Adult; Animals; Anti-Bacterial Agents; Cats; Clostridioides; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Neoplasm Recurrence, Local; Vancomycin	2023
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats. BMC veterinary research, 2023, Nov-16, Volume: 19, Issue:1 Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin	2023
Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection. Nature microbiology, 2019, Volume: 4, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cell Survival; Cephamycins; Chlorocebus aethiops; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Gene Expression Regulation, Bacterial; Genes, Bacterial; Male; Mice; Mice, Inbred C57BL; Penicillin-Binding Proteins; Spores, Bacterial; Vancomycin; Vero Cells	2019
Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 07-27, Volume: 71, Issue:3 Topics: Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci	2020
Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore. Scientific reports, 2019, 09-17, Volume: 9, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Female; Humans; Intensive Care Units; Male; Metronidazole; Recurrence; Risk Factors; Singapore; Treatment Outcome; Vancomycin	2019
Investigating the relationship between vancomycin-resistant Enterococcus control practices and the incidence of health care-associated Clostridioides difficile infections in Ontario. American journal of infection control, 2020, Volume: 48, Issue:3 Topics: Clostridioides; Clostridium Infections; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Health Facilities; Hospitals; Humans; Incidence; Infection Control; Ontario; Vancomycin; Vancomycin-Resistant Enterococci	2020
Perils, Pitfalls, and Promise of Primary Prophylaxis for Clostridioides difficile Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 08-22, Volume: 71, Issue:5 Topics: Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Delivery of Health Care; Humans; Vancomycin	2020
Clinical Predictors of Recurrence After Primary Clostridioides difficile Infection: A Prospective Cohort Study. Digestive diseases and sciences, 2020, Volume: 65, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors; Vancomycin	2020
Clostridioides difficile infection in immunocompromised hospitalized patients is associated with a high recurrence rate. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 90 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Hospitalization; Humans; Immunocompromised Host; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Recurrence; Risk Factors; Vancomycin	2020
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence. The American journal of gastroenterology, 2019, Volume: 114, Issue:12 Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Duration of Therapy; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Recurrence; Vancomycin; Young Adult	2019
Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-03, Volume: 71, Issue:9 Topics: Adult; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Retrospective Studies; Vancomycin	2020
Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015. Journal of general internal medicine, 2020, Volume: 35, Issue:2 Topics: Adult; Aged; Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Retrospective Studies; Vancomycin	2020
Moving the Needle on Clostridioides difficile Research in Children: A Major Step Forward but Challenges Remain. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-17, Volume: 71, Issue:10 Topics: Adolescent; Child; Clostridioides; Clostridium; Clostridium Infections; Fidaxomicin; Humans; Single-Blind Method; Vancomycin	2020
Commentary: faecal microbiota transplantation-from home brew to holy grail. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:1 Topics: Clostridium Infections; Colonoscopy; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Vancomycin	2020
Reply to McCreery et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 10-23, Volume: 71, Issue:7 Topics: Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Delivery of Health Care; Humans; Vancomycin	2020
Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon. BMC microbiology, 2020, 01-02, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Clindamycin; Clostridioides difficile; Clostridium Infections; Colon; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Microbial Viability; Models, Biological; Phylogeny; Real-Time Polymerase Chain Reaction; Vancomycin	2020
Potential impact of removing metronidazole from treatment armamentarium of mild acute Future microbiology, 2019, Volume: 14 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Female; Humans; Israel; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult	2019
Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:9 Topics: Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridium Infections; Cost-Benefit Analysis; Costs and Cost Analysis; Fecal Microbiota Transplantation; Fidaxomicin; Health Personnel; Hong Kong; Humans; Inflammatory Bowel Diseases; Public Health; Quality-Adjusted Life Years; Recurrence; Treatment Outcome; Vancomycin	2020
Oral Vancomycin Prophylaxis for Clostridioides difficile in High-Risk Patients Receiving Systemic Antibiotics: What Exactly Are We Preventing? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 10-23, Volume: 71, Issue:7 Topics: Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Delivery of Health Care; Humans; Vancomycin	2020
Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Drug Administration Routes; Female; Hospitalization; Hospitals; Humans; Immunoenzyme Techniques; Incidence; Inpatients; Japan; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Vancomycin	2020
The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:7 Topics: Anti-Bacterial Agents; Berberine; Biofilms; Chlorides; Clostridioides difficile; Clostridium Infections; Drug Synergism; Humans; Locomotion; Microbial Sensitivity Tests; Microbial Viability; Vancomycin	2020
The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:5 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Feces; Fidaxomicin; Gastrointestinal Microbiome; Humans; Mice; Microbiota; RNA, Ribosomal, 16S; Vancomycin	2020
Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:6 Topics: Aged; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Drug Utilization Review; Female; Fidaxomicin; Humans; Japan; Length of Stay; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Recurrence; Vancomycin	2020
Aryl-alkyl-lysines: Novel agents for treatment of C. difficile infection. Scientific reports, 2020, 03-27, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Caco-2 Cells; Cell Line, Tumor; Clostridioides difficile; Clostridium Infections; Humans; Lysine; Microbial Sensitivity Tests; Vancomycin	2020
Management of difficult-to-treat BMJ case reports, 2020, Mar-29, Volume: 13, Issue:3 Topics: Administration, Intravenous; Anti-Bacterial Agents; Clostridium Infections; Colitis; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Fecal Microbiota Transplantation; Fidaxomicin; Foot; Humans; Male; Metronidazole; Middle Aged; Osteomyelitis; Vancomycin	2020
The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan. Biological & pharmaceutical bulletin, 2020, Volume: 43, Issue:4 Topics: Anti-Bacterial Agents; Clostridium Infections; Drug Costs; Drug Utilization; Humans; Japan; Metronidazole; Vancomycin	2020
Necrotising enterocolitis caused by Clostridium perfringens: a life-threatening manifestation of a common foodborne infection. The Medical journal of Australia, 2020, Volume: 213, Issue:3 Topics: Adult; Clostridium Infections; Clostridium perfringens; Endoscopy, Digestive System; Enterocolitis, Necrotizing; Female; Food Microbiology; Humans; Ileostomy; Tomography, X-Ray Computed; Vancomycin	2020
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection. Pharmacotherapy, 2020, Volume: 40, Issue:5 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; APACHE; Clostridium Infections; Cohort Studies; Critical Illness; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Retrospective Studies; Vancomycin	2020
Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China. BMC infectious diseases, 2020, Apr-15, Volume: 20, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; China; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Female; Hospitals, Teaching; Humans; Incidence; Male; Metronidazole; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Risk Factors; Tertiary Care Centers; Vancomycin	2020
Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile. Scientific reports, 2020, 04-16, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Biofilms; Cell Membrane; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Bacterial; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron; Spores, Bacterial; Ticagrelor; Vancomycin	2020
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China. International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; China; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Moxifloxacin; Vancomycin	2020
In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection. Drugs in R&D, 2020, Volume: 20, Issue:3 Topics: Anti-Bacterial Agents; Auranofin; Clostridioides difficile; Clostridium Infections; Drug Repositioning; Metronidazole; Microbial Sensitivity Tests; Microbial Viability; Spores, Bacterial; Vancomycin	2020
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection. Scientific reports, 2020, 05-07, Volume: 10, Issue:1 Topics: Animals; Anti-Bacterial Agents; Arthritis, Rheumatoid; Auranofin; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Repositioning; Fidaxomicin; Gastrointestinal Tract; Humans; Mice; Microbial Sensitivity Tests; Recurrence; Vancomycin	2020
Impact of an antimicrobial stewardship program in the antimicrobial-resistant and prevalence of clostridioides difficile infection and amount of antimicrobial consumed in cancer patients. BMC research notes, 2020, May-19, Volume: 13, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Clostridium Infections; Comorbidity; Drug Resistance, Bacterial; Female; Humans; Immunocompromised Host; Iran; Male; Meropenem; Middle Aged; Neoplasms; Prevalence; Program Evaluation; Vancomycin; Young Adult	2020
Oral vancomycin prophylaxis against recurrent Infection control and hospital epidemiology, 2020, Volume: 41, Issue:8 Topics: Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Hospitals; Humans; Retrospective Studies; Vancomycin	2020
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis. Clinical and translational gastroenterology, 2020, Volume: 11, Issue:7 Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Comorbidity; Diagnostic Errors; Female; Fidaxomicin; Humans; Incidence; Lactulose; Laxatives; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Failure; Vancomycin	2020
Optimal vancomycin dose in the treatment of Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Antimicrobial Stewardship; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Serum Albumin; Severity of Illness Index; Sex Factors; Vancomycin	2021
Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients. Digestive diseases and sciences, 2020, Volume: 65, Issue:11 Topics: Anti-Bacterial Agents; Cholangitis, Sclerosing; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Colonoscopy; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence; Vancomycin; Young Adult	2020
Oral Vancomycin Prophylaxis for Clostridioides difficile Infection: Cause or Effect? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 11-02, Volume: 73, Issue:9 Topics: Clostridioides; Clostridioides difficile; Clostridium Infections; Humans; Vancomycin	2021
Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection. The Journal of infection, 2020, Volume: 81, Issue:5 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Fecal Microbiota Transplantation; Humans; Microbiota; Recurrence; Treatment Outcome; Vancomycin	2020
Clostridium tertium Peritonitis and Bacteremia in a Neonate With Congenital Intestinal Atresia: A Case Report. The Pediatric infectious disease journal, 2021, 02-01, Volume: 40, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Clostridium Infections; Clostridium tertium; Female; Humans; Infant, Newborn; Meropenem; Peritonitis; Splenic Infarction; Vancomycin	2021
Very low incidence of Haematologica, 2020, Sep-14, Volume: 106, Issue:5 Topics: Anemia, Sickle Cell; Child; Clostridioides; Clostridium Infections; Humans; Incidence; Vancomycin	2020
Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection". Pharmacotherapy, 2020, Volume: 40, Issue:9 Topics: Clostridioides; Clostridium Infections; Critical Illness; Humans; Metronidazole; Vancomycin	2020
Reply to Letters to the Editor. Pharmacotherapy, 2020, Volume: 40, Issue:9 Topics: Anti-Infective Agents; Clostridioides; Clostridium Infections; Critical Illness; Humans; Metronidazole; Vancomycin	2020
Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 103 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Fidaxomicin; Hospitalization; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Recurrence; Treatment Outcome; Vancomycin	2021
Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile. Gastroenterology, 2021, Volume: 160, Issue:3 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Drug Resistance, Bacterial; Germ-Free Life; Humans; Mice; Microbial Sensitivity Tests; Plasmids; Vancomycin; Whole Genome Sequencing	2021
Recurrent Clostridium difficile infection treated with bezlotoxumab in a liver transplant patient. Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:10 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Humans; Male; Middle Aged; Recurrence; Vancomycin	2021
Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis. Medical hypotheses, 2020, Volume: 144 Topics: Cholangitis, Sclerosing; Clostridium Infections; Dysbiosis; Humans; Inflammatory Bowel Diseases; Vancomycin	2020
A preliminary study of bowel rest strategy in the management of Clostridioides difficile infection. Scientific reports, 2020, 12-16, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease-Free Survival; Female; Humans; Male; Metronidazole; Retrospective Studies; Survival Rate; Vancomycin	2020
Comparative effectiveness of early-targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans' affairs patients with infections due to Clostridioides difficile. Pharmacotherapy, 2021, Volume: 41, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Hospitals, Veterans; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin	2021
Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study. International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Utilization; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin	2021
Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. NPJ biofilms and microbiomes, 2021, 02-05, Volume: 7, Issue:1 Topics: Aged; Aged, 80 and over; Bacteriological Techniques; Biofilms; Clostridioides difficile; Clostridium Infections; Colon; Fecal Microbiota Transplantation; Humans; Middle Aged; Models, Biological; Reinfection; Vancomycin	2021
Oral Immunotherapy With Human Secretory Immunoglobulin A Improves Survival in the Hamster Model of Clostridioides difficile Infection. The Journal of infectious diseases, 2021, 10-28, Volume: 224, Issue:8 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Humans; Immunoglobulin A; Immunoglobulin A, Secretory; Immunologic Factors; Immunotherapy; Vancomycin	2021
Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent clostridioides difficile. Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Comorbidity; Drug Administration Routes; Female; Fidaxomicin; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Vancomycin	2021
Changes in Metronidazole and Vancomycin Utilization for Nonsevere Clostridioides difficile Infection Among Institutions Caring for Children. The Pediatric infectious disease journal, 2021, 07-01, Volume: 40, Issue:7 Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Drug Utilization; Humans; Infant; Metronidazole; Vancomycin	2021
Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018. Anaerobe, 2021, Volume: 70 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Community-Acquired Infections; Female; Georgia; Guidelines as Topic; Humans; Male; Metronidazole; Middle Aged; Vancomycin	2021
Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:10 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Fidaxomicin; Humans; United States; Vancomycin	2021
Letter: faecal microbiota transplant in Clostridioides difficile infection: learning from the common water hyacinth. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:11 Topics: Clostridioides; Clostridium Infections; Eichhornia; Fecal Microbiota Transplantation; Humans; Vancomycin; Water	2021
Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:10 Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Female; Humans; Metronidazole; Retrospective Studies; Vancomycin	2021
Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities. Anaerobe, 2021, Volume: 70 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; United Kingdom; Vancomycin	2021
A prospective, observational study of fidaxomicin use for The Journal of international medical research, 2021, Volume: 49, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides; Clostridioides difficile; Clostridium Infections; Fidaxomicin; France; Humans; Prospective Studies; Vancomycin	2021
Vancomycin-resistant Acta clinica Croatica, 2020, Volume: 59, Issue:3 Topics: Anti-Bacterial Agents; Clostridium Infections; Enterococcus faecium; Humans; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci	2020
Oral Vancomycin as Secondary Prophylaxis for Pediatrics, 2021, Volume: 148, Issue:2 Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridium Infections; Cohort Studies; Female; Humans; Male; Retrospective Studies; Secondary Prevention; Vancomycin	2021
Toxigenic Epidemiology and infection, 2021, 08-10, Volume: 149 Topics: Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Clostridium Infections; Diarrhea; DNA, Bacterial; Drug Therapy, Combination; Enterotoxins; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Polymerase Chain Reaction; Treatment Outcome; Vancomycin	2021
Clostridium difficile: still costly, still difficult to treat, and still here. The Journal of hospital infection, 2017, Volume: 95, Issue:4 Topics: Clostridioides difficile; Clostridium Infections; Humans; Vancomycin	2017
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals. PloS one, 2017, Volume: 12, Issue:3 Topics: Anti-Bacterial Agents; Asian People; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Diarrhea; Electrophoresis, Gel, Pulsed-Field; Feces; Genes, Bacterial; Hospitals; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Reproducibility of Results; Republic of Korea; Ribotyping; Vancomycin	2017
An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:10 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Outbreaks; Female; Humans; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Recurrence; Ribotyping; Risk Factors; Spain; Survival Analysis; Treatment Outcome; Vancomycin; Young Adult	2017
Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing. Inflammatory bowel diseases, 2017, Volume: 23, Issue:6 Topics: Adolescent; Adult; Clostridium Infections; Colectomy; Cross-Sectional Studies; Escherichia coli; Feces; Female; Humans; Incidence; Inflammatory Bowel Diseases; Length of Stay; Logistic Models; Male; Middle Aged; New York City; Polymerase Chain Reaction; Recurrence; Vancomycin; Young Adult	2017
Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 10-01, Volume: 65, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Feces; Female; Humans; Male; Microbiota; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult	2017
Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Oct-15, Volume: 65, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Vancomycin	2017
Vancomycin vs Metronidazole for Clostridium difficile infection: focus on recurrence and mortality. Internal and emergency medicine, 2017, Volume: 12, Issue:6 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Risk Assessment; Secondary Prevention; Survival Analysis; Treatment Outcome; United States; Vancomycin	2017
Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study. PLoS medicine, 2017, Volume: 14, Issue:7 Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Clostridioides difficile; Clostridium Infections; Cohort Studies; Drug Combinations; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Surgical Wound Infection; United States; United States Department of Veterans Affairs; Vancomycin	2017
High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; China; Clostridioides difficile; Clostridium Infections; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Tigecycline; Vancomycin	2018
Antimicrobial susceptibility of Clostridium difficile isolates in Israel. Journal of global antimicrobial resistance, 2017, Volume: 10 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Combinations; Feces; Hospitals; Humans; Israel; Metronidazole; Microbial Sensitivity Tests; Ribotyping; Tigecycline; Vancomycin	2017
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 67 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Female; Genotype; Hospitals, General; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin; Young Adult	2018
Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries. World journal of surgery, 2018, Volume: 42, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Cross Infection; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Medicare; Metronidazole; Patient Readmission; Recurrence; Retrospective Studies; United States; Vancomycin	2018
Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis. Infection and immunity, 2017, Volume: 85, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Clostridium Infections; Drug Discovery; Drug Resistance, Bacterial; Feces; Fermentation; Gastrointestinal Microbiome; Glyceraldehyde; Glycerol; Humans; Limosilactobacillus reuteri; Metabolomics; Probiotics; Propane; Vancomycin	2017
An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection. PloS one, 2017, Volume: 12, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Computer Simulation; Drug Administration Schedule; Drug Dosage Calculations; Humans; Microbial Sensitivity Tests; Models, Statistical; Recurrence; Ribotyping; Spores, Bacterial; Vancomycin	2017
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable? Medecine et maladies infectieuses, 2017, Volume: 47, Issue:8 Topics: Adult; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Management; Female; Hematologic Neoplasms; Hospital Units; Hospitals, Teaching; Humans; Immunocompromised Host; Male; Medication Adherence; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin	2017
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients. The Annals of pharmacotherapy, 2018, Volume: 52, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Female; Humans; Kidney Transplantation; Male; Middle Aged; Recurrence; Secondary Prevention; Transplant Recipients; Vancomycin	2018
Characterization of Chicken IgY Specific to Frontiers in cellular and infection microbiology, 2017, Volume: 7 Topics: Adhesins, Bacterial; Administration, Oral; Animals; Antibodies, Bacterial; Bacterial Proteins; Caco-2 Cells; Chickens; Clostridioides difficile; Clostridium Infections; Colon; Diarrhea; Disease Models, Animal; Drug Combinations; Feces; Humans; Immunization, Passive; Immunoglobulin G; Immunoglobulins; Immunotherapy; Intestines; Mice; Mice, Inbred C57BL; Spores, Bacterial; Vancomycin	2017
Recurrent bacteremia and liver abscess caused by Clostridium difficile: A case report. Medicine, 2017, Volume: 96, Issue:35 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Translocation; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clostridioides difficile; Clostridium Infections; Humans; Liver Abscess; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Metronidazole; Recurrence; Vancomycin	2017
Fidaxomicin versus Vancomycin as a First-Line Treatment for Clostridium difficile-Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic Evaluation. Pharmacotherapy, 2017, Volume: 37, Issue:12 Topics: Aminoglycosides; Clostridium Infections; Cost Savings; Diarrhea; Fidaxomicin; Health Care Costs; Hospitalization; Humans; Models, Economic; Vancomycin	2017
Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Inpatients; Leukocyte Count; Male; Metronidazole; Middle Aged; Neutrophils; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin	2019
Successful treatment by fecal microbiota transplantation for Japanese patients with refractory Clostridium difficile infection: A prospective case series. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:4 Topics: Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Colonoscopy; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Humans; Japan; Male; Metronidazole; Prospective Studies; Treatment Outcome; Vancomycin	2019
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China. Journal of medical microbiology, 2018, Volume: 67, Issue:1 Topics: Anti-Infective Agents; Bacterial Proteins; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Tertiary Care Centers; Vancomycin	2018
Adverse Effects of Intravenous Vancomycin-Based Prophylaxis during Therapy for Pediatric Acute Myeloid Leukemia. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:3 Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Retrospective Studies; Vancomycin	2018
Is pulsed dosing the answer to treatment of Clostridium difficile infection? The Lancet. Infectious diseases, 2018, Volume: 18, Issue:3 Topics: Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Vancomycin	2018
Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Teicoplanin; Treatment Outcome; Vancomycin	2018
Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy. Infectious diseases (London, England), 2018, Volume: 50, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Croatia; Drug Therapy, Combination; Female; Hospitals, University; Humans; Infection Control; Male; Primary Prevention; Retrospective Studies; Vancomycin	2018
The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study. Internal medicine journal, 2018, Volume: 48, Issue:6 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome; Vancomycin	2018
Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections. Infection control and hospital epidemiology, 2018, Volume: 39, Issue:3 Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Fecal Microbiota Transplantation; Female; Humans; Male; Middle Aged; Recurrence; Regression, Psychology; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vancomycin; Young Adult	2018
The Rise and Fall of Metronidazole for Clostridium difficile Infection. The Annals of pharmacotherapy, 2018, Volume: 52, Issue:6 Topics: Anti-Bacterial Agents; Clostridium Infections; Humans; Metronidazole; Vancomycin	2018
Clostridium innocuum is a vancomycin-resistant pathogen that may cause antibiotic-associated diarrhoea. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Clostridium; Clostridium Infections; Diarrhea; Female; Humans; Infant; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Young Adult	2018
Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Models, Animal; Feces; Female; Fidaxomicin; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S; Vancomycin	2018
Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Fluoroquinolones; Humans; Lebanon; Male; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Phenotype; Ribotyping; Vancomycin	2018
Repeated Clostridium difficile infection after living donor liver transplantation. Clinical journal of gastroenterology, 2018, Volume: 11, Issue:4 Topics: Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Immunosuppressive Agents; Length of Stay; Liver Transplantation; Living Donors; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Vancomycin	2018
Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:3 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Recurrence; Retrospective Studies; Transplant Recipients; Treatment Outcome; Vancomycin	2018
Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Clindamycin; Clostridioides difficile; Clostridium Infections; Female; Humans; Israel; Male; Metronidazole; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; Secondary Prevention; Tertiary Care Centers; Vancomycin	2018
Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:8 Topics: Adolescent; ADP Ribose Transferases; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Clostridium Infections; Epidemiological Monitoring; Feces; Female; Hospitals, University; Humans; Inhibitory Concentration 50; Japan; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Ribotyping; Severity of Illness Index; Vancomycin; Young Adult	2018
Serum vancomycin concentrations after oral and intracolonic vancomycin administration in a patient with colonic discontinuity and severe American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018, May-01, Volume: 75, Issue:9 Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colon; Female; Humans; Intestinal Absorption; Middle Aged; Severity of Illness Index; Vancomycin	2018
[THE EPIDEMIOLOGY OF CLOSTRIDIUM DIFFICILE INFECTIONS AND ASPECTS PERTAINING TO TREATMENT WITH VANCOMYCIN AT ASSAF HAROFEH MEDICAL CENTER]. Harefuah, 2018, Volume: 157, Issue:5 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance	2018
The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2018, Apr-25, Volume: 108, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Drug Resistance, Bacterial; Fecal Microbiota Transplantation; Female; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Outcome and Process Assessment, Health Care; Recurrence; South Africa; Vancomycin	2018
The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan. International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:7 Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; Germany; Japan; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Swine; Taiwan; Tetracycline; Vancomycin	2018
Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China. Medicine, 2018, Volume: 97, Issue:25 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Beijing; China; Clostridioides difficile; Clostridium Infections; Disease Outbreaks; Drug Resistance, Microbial; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Vancomycin	2018
Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting. International journal of colorectal disease, 2018, Volume: 33, Issue:9 Topics: Adult; Age Factors; Ambulatory Care; Anti-Bacterial Agents; Anti-Inflammatory Agents; Brazil; Clostridium Infections; Colitis, Ulcerative; Crohn Disease; Disease Progression; Female; Humans; Infliximab; Male; Middle Aged; Prevalence; Prospective Studies; Recurrence; Risk Factors; Sex Factors; Steroids; Time Factors; Treatment Outcome; Vancomycin	2018
Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant. Hematology/oncology and stem cell therapy, 2018, Volume: 11, Issue:4 Topics: Acute Disease; Administration, Oral; Adult; Aged; Allografts; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Time Factors; Vancomycin	2018
The evolving epidemiology of CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2018, 06-25, Volume: 190, Issue:25 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Canada; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult	2018
Highly antibiotic-resistant Clostridium difficile isolates from Iranian patients. Journal of applied microbiology, 2018, Volume: 125, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Iran; Metronidazole; Microbial Sensitivity Tests; Vancomycin	2018
Comparative efficacy of antibiotics in treating experimental Clostridium septicum infection. International journal of antimicrobial agents, 2018, Volume: 52, Issue:4 Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Clostridium septicum; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Injections, Intraperitoneal; Mice; Microbial Sensitivity Tests; Muscle, Skeletal; Penicillins; Soft Tissue Infections; Survival Analysis; Tetracycline; Vancomycin	2018
Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides difficile; Clostridium Infections; Cricetinae; Female; Vancomycin	2018
Firvanq--vancomycin oral solution. The Medical letter on drugs and therapeutics, 2018, 07-16, Volume: 60, Issue:1551 Topics: Administration, Oral; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Drug Approval; Enterocolitis; Humans; Methicillin-Resistant Staphylococcus aureus; Solutions; Staphylococcal Infections; Staphylococcus aureus; United States; United States Food and Drug Administration; Vancomycin	2018
Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection. PloS one, 2018, Volume: 13, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; China; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Decision Support Techniques; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Gene Frequency; Humans; Male; Middle Aged; Ribotyping; Severity of Illness Index; Survival Rate; Treatment Outcome; Vancomycin	2018
Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile. Journal of medical microbiology, 2018, Volume: 67, Issue:9 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Kinetics; Microbial Sensitivity Tests; Oxazolidinones; Ribotyping; Vancomycin	2018
Clostridium difficile infection in young people - 2 case reports. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2018, Jun-27, Volume: 44, Issue:264 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Ceftriaxone; Clostridioides difficile; Clostridium Infections; Female; Humans; Metronidazole; Risk Factors; Salmonella enteritidis; Salmonella Infections; Salmonella typhi; Treatment Outcome; Vancomycin	2018
Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro. International journal of antimicrobial agents, 2018, Volume: 52, Issue:5 Topics: Anti-Bacterial Agents; Bacteriolysis; Cell Division; Clostridioides difficile; Clostridium Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Spores, Bacterial; Vancomycin; Xanthones	2018
Diagnosis and Treatment of Clostridium difficile Infection. JAMA, 2018, Sep-11, Volume: 320, Issue:10 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Nucleic Acid Amplification Techniques; Practice Guidelines as Topic; Recurrence; Vancomycin	2018
Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program. Infection control and hospital epidemiology, 2018, Volume: 39, Issue:9 Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clostridium Infections; Female; Hospitals, Veterans; Humans; Incidence; Male; Middle Aged; Pacemaker, Artificial; Proportional Hazards Models; Prosthesis-Related Infections; Quality Improvement; Time Factors; United States; Vancomycin	2018
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 05-30, Volume: 68, Issue:12 Topics: Administration, Oral; Adult; Aged; Antibiotic Prophylaxis; Clostridioides difficile; Clostridium Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hypersensitivity; Male; Middle Aged; Prognosis; Retrospective Studies; Time-to-Treatment; Transplant Recipients; Transplantation, Homologous; Vancomycin; Young Adult	2019
Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition, 2019, Volume: 68, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Child; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Recurrence; Retrospective Studies; Severity of Illness Index; Vancomycin	2019
Fidaxomicin in the treatment of Clostridium difficile infection in oncohematology patients. Medicina clinica, 2019, 10-11, Volume: 153, Issue:7 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonic Neoplasms; Diarrhea; Female; Fidaxomicin; Hematologic Neoplasms; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin	2019
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection. Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Female; Fidaxomicin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Treatment Failure; Treatment Outcome; Vancomycin	2019
What Is the Role for Metronidazole in the Treatment of Clostridium difficile Infection? Results From a National Cohort Study of Veterans With Initial Mild Disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 09-27, Volume: 69, Issue:8 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Logistic Models; Male; Metronidazole; Vancomycin; Veterans	2019
Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Databases, Factual; Disease Management; Female; Fidaxomicin; Humans; Male; Middle Aged; Propensity Score; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United States; Vancomycin	2019
Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection. BMC infectious diseases, 2019, Jan-14, Volume: 19, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin	2019
The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran. Journal of global antimicrobial resistance, 2019, Volume: 18 Topics: Aged; Aged, 80 and over; Animals; Chlorocebus aethiops; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Feces; Female; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Vancomycin; Vero Cells	2019
Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years. Current microbiology, 2019, Volume: 76, Issue:4 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Epidemiological Monitoring; Feces; Germany; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; Tertiary Care Centers; Vancomycin	2019
Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 01-01, Volume: 70, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Ecological and Environmental Phenomena; Female; Fluoroquinolones; Hospitalization; Hospitals; Humans; Interrupted Time Series Analysis; Male; Metronidazole; Middle Aged; United States; Vancomycin	2020
Vancomycin dependent Enterococcus: an unusual mutant? Pathology, 2019, Volume: 51, Issue:3 Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Enterococcus; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Vancomycin	2019
Recurrent Clostridioides (Clostridium) difficile infection in a patient suffering from inflammatory bowel disease and benefits of resistotyping. Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Typing Techniques; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Feces; Humans; Male; Multilocus Sequence Typing; Recurrence; Vancomycin	2019
Evaluation of Rectal Vancomycin Irrigation for Treatment of Surgical infections, 2019, Volume: 20, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Colectomy; Colitis; Female; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Survival Analysis; Therapeutic Irrigation; Treatment Outcome; Vancomycin	2019
Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals; Humans; Inpatients; Japan; Logistic Models; Male; Metronidazole; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin	2019
Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Fidaxomicin; Health Care Costs; Humans; Middle Aged; Models, Economic; National Health Programs; Quality-Adjusted Life Years; Spain; Treatment Outcome; Vancomycin	2019
Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses. Infection control and hospital epidemiology, 2019, Volume: 40, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Logistic Models; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Vancomycin	2019
Infectious diseases (London, England), 2019, Volume: 51, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Clostridium Infections; Croatia; Female; Guideline Adherence; Humans; Infant; Infant, Newborn; Male; Metronidazole; Middle Aged; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Vancomycin; Young Adult	2019
Risk factors and outcomes of Clostridium difficile infection in hospitalized patients. Biomedical journal, 2019, Volume: 42, Issue:2 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Outcome; Vancomycin	2019
Vancomycin prophylaxis for Clostridium difficile infection among lung transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2019, Volume: 38, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Vancomycin	2019
Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation. Transplantation, 2020, Volume: 104, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Feces; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Intestine, Small; Male; Metronidazole; Postoperative Complications; Prevalence; Recurrence; Retrospective Studies; Risk Factors; Vancomycin	2020
Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:10 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Transplantation Conditioning; Vancomycin	2019
An ultra-sensitive UHPLC-MS/MS assay for the quantification of orally administered vancomycin in plasma. Journal of pharmaceutical and biomedical analysis, 2019, Sep-10, Volume: 174 Topics: Administration, Oral; Adult; Animals; Blood Chemical Analysis; Calibration; Chromatography, High Pressure Liquid; Clostridium Infections; Dogs; Drug Monitoring; Female; Humans; Immunoassay; Male; Middle Aged; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry; Vancomycin	2019
Does oral vancomycin prophylaxis during systemic antibiotic exposure prevent Clostridioides difficile infection relapses? Still in search of an answer. Infection control and hospital epidemiology, 2019, Volume: 40, Issue:9 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Recurrence; Vancomycin	2019
High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates. PloS one, 2019, Volume: 14, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Linezolid; Microbiota; Quorum Sensing; Recurrence; Ribotyping; Spores, Bacterial; Vancomycin; Virulence Factors	2019
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Europe; Fidaxomicin; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Thiazoles; Treatment Outcome; Vancomycin	2013
A new strategy for the prevention of Clostridium difficile infection. The Journal of infectious diseases, 2013, May-15, Volume: 207, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides difficile; Clostridium Infections; Colistin; Diarrhea; Dose-Response Relationship, Drug; Feces; Female; Gentamicins; Kanamycin; Metagenome; Metronidazole; Mice; Mice, Inbred C57BL; Spores, Bacterial; Vancomycin	2013
Impact of ribotype 027 on Clostridium difficile infection in a geriatric department. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:9 Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fluoroquinolones; Health Services for the Aged; Humans; Retrospective Studies; Ribotyping; Risk Factors; Treatment Outcome; Vancomycin	2013
MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colon; Diarrhea; Disease Models, Animal; Drug Evaluation, Preclinical; Fluoroquinolones; Germ-Free Life; Kaplan-Meier Estimate; Pyrimidinones; Severity of Illness Index; Swine; Treatment Outcome; Vancomycin	2013
Candidemia subsequent to severe infection due to Clostridium difficile: is there a link? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:5 Topics: Aminoglycosides; Candida; Clostridioides difficile; Clostridium Infections; Enterococcus; Female; Humans; Male; Vancomycin	2013
Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. The Journal of hospital infection, 2013, Volume: 85, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Male; Metronidazole; Middle Aged; Organizational Policy; Severity of Illness Index; Treatment Outcome; Vancomycin	2013
Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection. The Journal of hospital infection, 2013, Volume: 85, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult	2013
The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea. Journal of pharmacy practice, 2013, Volume: 26, Issue:5 Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Costs; Humans; Metronidazole; Severity of Illness Index; Vancomycin	2013
Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:2 Topics: Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Gastrointestinal Tract; Humans; Metronidazole; Microbial Sensitivity Tests; Models, Biological; Treatment Failure; Treatment Outcome; Vancomycin	2014
Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole. PloS one, 2013, Volume: 8, Issue:10 Topics: Administration, Oral; Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Feces; Female; Humans; Male; Metronidazole; Microbiota; Middle Aged; Prospective Studies; Vancomycin	2013
Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection. International journal of antimicrobial agents, 2013, Volume: 42, Issue:6 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin	2013
Clostridium difficile bacteremia. Surgical infections, 2013, Volume: 14, Issue:6 Topics: Anti-Bacterial Agents; Bacteremia; Clostridioides difficile; Clostridium Infections; Humans; Intestinal Perforation; Levofloxacin; Lymphoma, Mantle-Cell; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin	2013
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Fluoroquinolones; Humans; Linezolid; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Spores, Bacterial; Survival Analysis; Vancomycin	2014
Comparison of oral vancomycin capsule and solution for treatment of initial episode of severe Clostridium difficile Infection. Journal of pharmacy practice, 2015, Volume: 28, Issue:2 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Capsules; Clostridioides difficile; Clostridium Infections; Cohort Studies; Humans; Middle Aged; Proportional Hazards Models; Retrospective Studies; Solutions; Vancomycin	2015
Therapeutic approaches for Clostridium difficile infections. Current protocols in microbiology, 2013, Oct-02, Volume: 30 Topics: Aminoglycosides; Anti-Infective Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitoxins; Bacterial Vaccines; Biological Therapy; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Fidaxomicin; Humans; Immunotherapy; Metronidazole; Vancomycin	2013
Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ribotyping; United States; Vancomycin; Vancomycin Resistance	2014
Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin	2014
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Retrospective Studies; Treatment Outcome; Vancomycin	2014
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2014, Volume: 27, Issue:2 Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin	2014
In vivo assessment of SMT19969 in a hamster model of clostridium difficile infection. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Male; Mesocricetus; Metronidazole; Microbial Sensitivity Tests; Vancomycin	2014
Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. PloS one, 2014, Volume: 9, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, University; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Texas; Vancomycin	2014
Clostridium difficile infection and Candida colonization of the gut: is there a correlation? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Dec-01, Volume: 59, Issue:11 Topics: Aminoglycosides; Candida; Clostridioides difficile; Clostridium Infections; Enterococcus; Female; Humans; Male; Vancomycin	2014
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Fidaxomicin; Humans; Markov Chains; Vancomycin	2014
Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection. Anaerobe, 2014, Volume: 30 Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Clostridium; Clostridium Infections; Cytomegalovirus Infections; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin; Vancomycin Resistance	2014
High frequency of nonadherence to Clostridium difficile treatment guidelines. Southern medical journal, 2014, Volume: 107, Issue:9 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Critical Pathways; Decision Support Systems, Clinical; Guideline Adherence; Humans; Metronidazole; Patient Selection; Practice Guidelines as Topic; Retrospective Studies; Severity of Illness Index; Vancomycin	2014
Commentary on "High frequency of nonadherence to Clostridium difficile treatment guidelines". Southern medical journal, 2014, Volume: 107, Issue:9 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Guideline Adherence; Humans; Metronidazole; Vancomycin	2014
Clostridium colitis: challenges in diagnosis and treatment. ANZ journal of surgery, 2017, Volume: 87, Issue:4 Topics: ADP Ribose Transferases; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Clostridium Infections; Colitis; Combined Modality Therapy; Disease Management; Female; Humans; Ileostomy; Male; Middle Aged; Retrospective Studies; Vancomycin; Young Adult	2017
Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:12 Topics: Anti-Bacterial Agents; Biological Therapy; Clostridioides difficile; Clostridium Infections; Computer Simulation; Cost-Benefit Analysis; Humans; Metronidazole; Quality-Adjusted Life Years; Vancomycin	2014
Emphysematous cystitis due to recurrent Clostridium difficile infection. BMJ case reports, 2014, Dec-17, Volume: 2014 Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cystitis; Emphysema; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Metronidazole; Recurrence; Urinary Bladder; Vancomycin	2014
Clostridium difficile Ileitis in Pediatric Inflammatory Bowel Disease. Journal of pediatric gastroenterology and nutrition, 2017, Volume: 64, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Ileitis; Inflammatory Bowel Diseases; Tomography, X-Ray Computed; Vancomycin	2017
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:6 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzimidazoles; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Fidaxomicin; Gastrointestinal Tract; Mesocricetus; Microbial Sensitivity Tests; Plasma; Pyridines; Recurrence; Survival Analysis; Treatment Outcome; Vancomycin	2015
Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection. Pharmacotherapy, 2015, Volume: 35, Issue:2 Topics: Academic Medical Centers; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Female; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Risk Factors; Vancomycin	2015
Impact of Clostridium difficile recurrence on hospital readmissions. American journal of infection control, 2015, Apr-01, Volume: 43, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Fluoroquinolones; Humans; Intensive Care Units; Linezolid; Multivariate Analysis; Patient Readmission; Recurrence; Regression Analysis; Retrospective Studies; Vancomycin	2015
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015, Volume: 21, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Candidemia; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Enterocolitis; Female; Humans; Male; Middle Aged; Retrospective Studies; Ribotyping; Risk Factors; Survival Analysis; Treatment Outcome; Vancomycin	2015
Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Gastrointestinal Tract; Humans; Middle Aged; Models, Theoretical; Recurrence; Treatment Outcome; Vancomycin	2015
Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia. Anaerobe, 2015, Volume: 34 Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fluoroquinolones; Genetic Variation; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Vancomycin; Victoria	2015
Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Colonoscopy; Fecal Microbiota Transplantation; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Sepsis; Shock, Septic; Vancomycin	2015
A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole. Diagnostic microbiology and infectious disease, 2015, Volume: 83, Issue:1 Topics: Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Incidence; Israel; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Ribotyping; Vancomycin	2015
Clostridium difficile Relapse Secondary to Medication Access Issue. AORN journal, 2015, Volume: 102, Issue:1 Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Vancomycin; Young Adult	2015
Total Synthesis of the Glycosylated Macrolide Antibiotic Fidaxomicin. Organic letters, 2015, Jul-17, Volume: 17, Issue:14 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Glycosylation; Macrolides; Molecular Structure; Vancomycin	2015
[Analysis of Clostridium difficile associated diarrhea in pediatric patients with antibiotic-associated diarrhea]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2015, Volume: 53, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Humans; Incidence; Metronidazole; Probiotics; Vancomycin	2015
[Fecal microbiota transplantation in recurrent Clostridium difficile infection. Report of one case]. Revista medica de Chile, 2015, Volume: 143, Issue:4 Topics: Clostridioides difficile; Clostridium Infections; Diarrhea; Fecal Microbiota Transplantation; Female; Humans; Middle Aged; Recurrence; Vancomycin	2015
Routine disc diffusion antimicrobial susceptibility testing of Clostridium difficile and association with PCR ribotype 027. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:11 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Metronidazole; Ribotyping; Vancomycin	2015
Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11 Topics: Aminoglycosides; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Retrospective Studies; Vancomycin	2015
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:8 Topics: Anti-Bacterial Agents; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Male; Vancomycin	2015
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection--authors' reply. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:8 Topics: Anti-Bacterial Agents; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Male; Vancomycin	2015
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Diarrhea; Fidaxomicin; Humans; Kidney Diseases; Neoplasms; Quality-Adjusted Life Years; Spain; Treatment Outcome; Vancomycin	2015
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Aged; Anti-Infective Agents; Bacteremia; Candida; Candidiasis; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Coinfection; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Multivariate Analysis; Odds Ratio; Risk Factors; Survival Analysis; Treatment Outcome; Vancomycin	2016
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Nov-01, Volume: 72, Issue:21 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Metronidazole; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin	2015
Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. The Journal of thoracic and cardiovascular surgery, 2016, Volume: 151, Issue:2 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Clostridioides difficile; Clostridium Infections; Coronary Artery Bypass; Databases, Factual; Drug Administration Schedule; Drug Therapy, Combination; Humans; Logistic Models; Multivariate Analysis; Odds Ratio; Practice Patterns, Physicians'; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Vancomycin	2016
Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital. Journal of clinical pharmacy and therapeutics, 2015, Volume: 40, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Canada; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Management; Female; Hospitals, Teaching; Humans; Length of Stay; Male; Microbiology; Middle Aged; Pharmacy Service, Hospital; Prospective Studies; Retrospective Studies; Severity of Illness Index; Vancomycin; Young Adult	2015
Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Benzimidazoles; Ceftriaxone; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Fidaxomicin; Fluoroquinolones; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Phenotype; Pyridines; Ribotyping; Vancomycin	2016
Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013. Epidemiology and infection, 2016, Volume: 144, Issue:7 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Candida; Candidemia; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Female; Georgia; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Prevalence; Risk Factors; Vancomycin; Young Adult	2016
Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection. The Journal of infectious diseases, 2016, 07-01, Volume: 214, Issue:1 Topics: Age Factors; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Gastrointestinal Microbiome; Humans; Immunity, Humoral; Mice, Inbred C57BL; Models, Animal; Vancomycin	2016
A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin. Annals of clinical microbiology and antimicrobials, 2016, Apr-12, Volume: 15 Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Feces; Female; Fidaxomicin; Humans; Male; Middle Aged; Pilot Projects; Vancomycin	2016
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases. BMC infectious diseases, 2016, Apr-22, Volume: 16 Topics: Adult; Aged; Aged, 80 and over; Clostridium Infections; Databases, Factual; Female; Health Care Costs; Hospitals; Humans; Incidence; Longitudinal Studies; Male; Medicare; Metronidazole; Middle Aged; Retrospective Studies; United States; Vancomycin	2016
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks. Emerging microbes & infections, 2016, May-11, Volume: 5 Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin	2016
Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Sep-01, Volume: 63, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clostridioides difficile; Clostridium Infections; Female; Humans; Incidence; Male; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Vancomycin	2016
Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection. BMC infectious diseases, 2016, 06-22, Volume: 16 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Feces; Female; Hospitalization; Hospitals; Humans; Immunoassay; Inflammation; Israel; Leukocyte L1 Antigen Complex; Leukocytosis; Male; Metronidazole; Middle Aged; Recurrence; Ribotyping; Severity of Illness Index; Vancomycin; Young Adult	2016
Editorial Commentary: Where to Place the New Treatments for Clostridium difficile Infection? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 09-15, Volume: 63, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Vancomycin	2016
Review: NAATs diagnose C difficile; vancomycin improves cure, and fidaxomicin reduces recurrence. Annals of internal medicine, 2016, 07-19, Volume: 165, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Nucleic Acid Amplification Techniques; Secondary Prevention; Vancomycin	2016
Pseudomembranous colitis presenting as a mechanical large bowel obstruction. ANZ journal of surgery, 2018, Volume: 88, Issue:9 Topics: Administration, Intravenous; Administration, Oral; Anastomosis, Surgical; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Diatrizoate Meglumine; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Intestinal Obstruction; Male; Metronidazole; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin	2018
Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Clinical Decision-Making; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Organ Transplantation; Retrospective Studies; Tacrolimus; Treatment Outcome; Vancomycin	2016
Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Antitoxins; Bacterial Proteins; Bacterial Toxins; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Convalescence; Cricetulus; Disease Models, Animal; Disease Progression; Enterotoxins; Gastrointestinal Microbiome; Humans; Mice; Mice, Inbred C57BL; Survival Analysis; Vancomycin	2016
Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 11-15, Volume: 63, Issue:10 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Vancomycin	2016
Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections. The American journal of gastroenterology, 2016, Volume: 111, Issue:12 Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Quebec; Recurrence; Retrospective Studies; Secondary Prevention; Vancomycin; Young Adult	2016
Hypersensitivity Reaction Following Administration of Low-Dose Oral Vancomycin for the Treatment of Clostridium difficile in a Patient With Normal Renal Function. Journal of pharmacy practice, 2017, Volume: 30, Issue:6 Topics: Administration, Oral; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Hypersensitivity; Fidaxomicin; Humans; Kidney; Male; Middle Aged; Treatment Outcome; Vancomycin	2017
Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel. Diagnostic microbiology and infectious disease, 2016, Volume: 86, Issue:4 Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; Israel; Metronidazole; Prospective Studies; Tertiary Care Centers; Vancomycin	2016
Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis. Expert opinion on drug safety, 2016, Volume: 15, Issue:12 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Databases, Factual; Humans; Proton Pump Inhibitors; Vancomycin	2016
ECCMID 2016: addressing the burden of recurrent Clostridium difficile infections. Future microbiology, 2016, Volume: 11 Topics: Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Congresses as Topic; Cost of Illness; Cross Infection; Enterotoxins; Europe; Gastrointestinal Microbiome; Humans; Netherlands; Vancomycin	2016
High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana. International journal of medical microbiology : IJMM, 2016, Volume: 306, Issue:8 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Carrier State; Ceftriaxone; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Feces; Female; Ghana; Hospitalization; Humans; Infant; Infant, Newborn; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Ribotyping; Risk Factors; Rural Population; Vancomycin; Young Adult	2016
Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Infant; Infant, Newborn; Italy; Male; Metronidazole; Prevalence; Recurrence; Retrospective Studies; Risk Assessment; Treatment Outcome; Vancomycin	2017
The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Frontiers in cellular and infection microbiology, 2016, Volume: 6 Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Antitoxins; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Gastrointestinal Microbiome; Longitudinal Studies; Mice; Survival Analysis; Treatment Outcome; Vancomycin	2016
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5 Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Capillary; Female; Fluoroquinolones; Gene Expression; Humans; Male; Methyltransferases; Metronidazole; Microbial Sensitivity Tests; Minisatellite Repeats; Moxifloxacin; Multilocus Sequence Typing; Retrospective Studies; Ribotyping; Tertiary Care Centers; Vancomycin	2017
An institutional comparison of total abdominal colectomy and diverting loop ileostomy and colonic lavage in the treatment of severe, complicated Clostridium difficile infections. American journal of surgery, 2017, Volume: 213, Issue:3 Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Colectomy; Colon; Female; Humans; Ileostomy; Male; Metronidazole; Middle Aged; Organ Sparing Treatments; Recurrence; Retrospective Studies; Severity of Illness Index; Therapeutic Irrigation; Vancomycin; Virginia	2017
Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach. Gut microbes, 2017, 05-04, Volume: 8, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Cohort Studies; Colectomy; Colonoscopy; Fecal Microbiota Transplantation; Feces; Female; Follow-Up Studies; Freezing; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Risk Factors; Survival Rate; Treatment Outcome; Vancomycin	2017
Fecal Fixation: Fecal Microbiota Transplantation for Clostridium difficile Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 02-01, Volume: 64, Issue:3 Topics: Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Feces; Humans; Vancomycin	2017
Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality. The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:2 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Male; Medical Records; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin	2017
Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection. JAMA internal medicine, 2017, 04-01, Volume: 177, Issue:4 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Assessment; Secondary Prevention; Survival Analysis; Treatment Outcome; United States; Vancomycin	2017
Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients. Pharmacotherapy, 2017, Volume: 37, Issue:4 Topics: Academic Medical Centers; Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Time Factors; Transplantation Conditioning; Vancomycin	2017
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France. Journal of medical economics, 2017, Volume: 20, Issue:7 Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; France; Hospitalization; Humans; Markov Chains; Models, Economic; Neoplasms; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; Severity of Illness Index; Vancomycin	2017
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. Nederlands tijdschrift voor geneeskunde, 2008, Aug-30, Volume: 152, Issue:35 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vancomycin	2008
Management of Clostridium difficile infection: survey of practices and compliance with national guidelines among primary care physicians. Infection control and hospital epidemiology, 2009, Volume: 30, Issue:4 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Guideline Adherence; Health Care Surveys; Metronidazole; Physicians, Family; Practice Guidelines as Topic; Practice Patterns, Physicians'; Vancomycin	2009
Clostridium difficile infections: emerging epidemiology and new treatments. Journal of pediatric gastroenterology and nutrition, 2009, Volume: 48 Suppl 2 Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Humans; Immunotherapy; Inflammatory Bowel Diseases; Probiotics; Risk Factors; Vancomycin; Virulence Factors	2009
Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older. Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:4 Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Logistic Models; Male; Metronidazole; Michigan; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Vancomycin	2009
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment. Anaerobe, 2009, Volume: 15, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Agents; Humans; Male; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome; Vancomycin	2009
Clostridium difficile infection: historic review. Anaerobe, 2009, Volume: 15, Issue:6 Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Female; Guinea Pigs; History, 20th Century; Humans; Metronidazole; Vancomycin; Young Adult	2009
Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection. Infection control and hospital epidemiology, 2009, Volume: 30, Issue:11 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Cross-Sectional Studies; Female; Humans; International Classification of Diseases; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; United States; United States Dept. of Health and Human Services; Vancomycin	2009
Stool transplantation for older patients with Clostridium difficile infection. Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:12 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Feces; Humans; Omeprazole; Probiotics; Recurrence; Vancomycin	2009
Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients. The Journal of hospital infection, 2010, Volume: 74, Issue:4 Topics: Aged, 80 and over; Albumins; Anti-Bacterial Agents; C-Reactive Protein; Clostridioides difficile; Clostridium Infections; Creatinine; Cross Infection; Diarrhea; Female; Hospitals; Humans; Leukocyte Count; Male; Metronidazole; Time Factors; United Kingdom; Vancomycin	2010
Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutritional neuroscience, 2010, Volume: 13, Issue:3 Topics: Acute Disease; Adolescent; Adult; Autistic Disorder; Child; Child, Preschool; Clostridioides difficile; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Phenylalanine; Phenylpropionates; Schizophrenia; Sex Characteristics; Vancomycin; Young Adult	2010
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:10 Topics: Adolescent; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Feces; Female; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence; Recurrence; Ribotyping; Rifampin; Severity of Illness Index; Vancomycin	2010
[Approach to the treatment of intestinal infectious diseases caused by Clostridium difficile]. Klinicka mikrobiologie a infekcni lekarstvi, 2010, Volume: 16, Issue:3 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Vancomycin	2010
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection. BMC infectious diseases, 2010, Dec-30, Volume: 10 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Vancomycin	2010
The search for effective treatment of Clostridium difficile infection. The New England journal of medicine, 2011, Feb-03, Volume: 364, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Secondary Prevention; Vancomycin	2011
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Humans; Mesocricetus; Metronidazole; Oxazolidinones; Spores, Bacterial; Vancomycin	2011
Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain. Infection, 2011, Volume: 39, Issue:4 Topics: Adult; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Comorbidity; Humans; Male; Ohio; Treatment Outcome; Vancomycin	2011
Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2011, Volume: 30, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Diarrhea; Enzyme-Linked Immunosorbent Assay; Feces; Female; Hospitals, General; Humans; India; Male; Metronidazole; Middle Aged; Prevalence; Retrospective Studies; Vancomycin	2011
Fidaxomicin for Clostridium difficile Infection. The New England journal of medicine, 2011, 05-12, Volume: 364, Issue:19 Topics: Aminoglycosides; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Enterotoxins; Fidaxomicin; Humans; Secondary Prevention; Vancomycin	2011
Fidaxomicin for Clostridium difficile infection. The New England journal of medicine, 2011, 05-12, Volume: 364, Issue:19 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Proton Pump Inhibitors; Secondary Prevention; Vancomycin	2011
Mouse relapse model of Clostridium difficile infection. Infection and immunity, 2011, Volume: 79, Issue:7 Topics: Animals; Anti-Bacterial Agents; Antibodies, Neutralizing; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Enterocolitis, Pseudomembranous; Enterotoxins; Mice; Mice, Inbred C57BL; Secondary Prevention; Vancomycin	2011
Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: a spatial and time series analysis. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:7 Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cluster Analysis; Drug Prescriptions; Drug Utilization; Humans; Linear Models; Ohio; Population Surveillance; Seasons; Vancomycin	2011
Vancomycin "telephone". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jul-15, Volume: 53, Issue:2 Topics: Administration, Oral; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Treatment Outcome; Vancomycin	2011
Clostridium difficile disease and vancomycin--questionable clinical superiority. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jul-15, Volume: 53, Issue:2 Topics: Administration, Oral; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Treatment Outcome; Vancomycin	2011
[Left-sided ulcerative colitis reactivated and aggravated during clostridium difficile infection]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 57, Issue:6 Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Colonoscopy; Drug Therapy, Combination; Feces; Female; Humans; Metronidazole; Middle Aged; Sulfasalazine; Vancomycin	2011
Clostridium difficile infection causing multiple organ failure and small-bowel enteritis. Clinics and research in hepatology and gastroenterology, 2011, Volume: 35, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enteritis; Esophageal Neoplasms; Esophagectomy; Humans; Intestine, Small; Length of Stay; Male; Metronidazole; Middle Aged; Multiple Organ Failure; Time Factors; Treatment Outcome; Vancomycin	2011
Fewer recurrent infections of C. difficile seen with fidaxomicin. This new class of antibiotic--the macrocycles--has a greater sustained response against re-infection than vancomycin. Managed care (Langhorne, Pa.), 2011, Volume: 20, Issue:7 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Comparative Effectiveness Research; Cost-Benefit Analysis; Fidaxomicin; Humans; Secondary Prevention; Vancomycin	2011
Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Annals of surgery, 2011, Volume: 254, Issue:3 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Colon; Enterocolitis, Pseudomembranous; Female; Humans; Ileostomy; Male; Middle Aged; Odds Ratio; Pennsylvania; Polyethylene Glycols; Retrospective Studies; Severity of Illness Index; Survival Rate; Therapeutic Irrigation; Vancomycin	2011
Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Decision Making; Drug Prescriptions; Enterotoxins; Feces; Female; Glutamate Dehydrogenase; Humans; Immunoenzyme Techniques; Male; Metronidazole; Middle Aged; Neutralization Tests; Polymerase Chain Reaction; Practice Patterns, Physicians'; Retrospective Studies; Vancomycin; Young Adult	2011
Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital. Journal of Korean medical science, 2011, Volume: 26, Issue:10 Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Republic of Korea; Treatment Outcome; Vancomycin	2011
Preventing downstream Clostridium difficile infections with upstream antibiotic management. Medical hypotheses, 2012, Volume: 78, Issue:1 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin	2012
Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital. American journal of infection control, 2012, Volume: 40, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Utilization; Female; Hospitals, Community; Humans; Male; Metronidazole; Molecular Diagnostic Techniques; Patient Isolation; Real-Time Polymerase Chain Reaction; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin	2012
Vancomycin-induced cutaneous vasculitis. British journal of hospital medicine (London, England : 2005), 2012, Volume: 73, Issue:3 Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Male; Vancomycin; Vasculitis	2012
Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection. Infection control and hospital epidemiology, 2012, Volume: 33, Issue:6 Topics: Aged; Anti-Bacterial Agents; Asymptomatic Infections; Bacterial Shedding; Clostridioides difficile; Clostridium Infections; Critical Care; Cross Infection; Female; Hospitals, Veterans; Humans; Male; Ohio; Patient Isolation; Residential Facilities; Time Factors; Vancomycin	2012
Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzamides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Enzyme Inhibitors; Fidaxomicin; Mice; Microbial Sensitivity Tests; Nitro Compounds; Pyruvate Synthase; Thiazoles; Treatment Outcome; Vancomycin	2012
Clostridium difficile infection, Colorado and the northwestern United States, 2007. Emerging infectious diseases, 2012, Volume: 18, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colorado; Female; Humans; Incidence; Male; Metronidazole; Middle Aged; Northwestern United States; Vancomycin; Young Adult	2012
Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection. BMJ case reports, 2011, Nov-21, Volume: 2011 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Male; Metronidazole; Nitro Compounds; Recurrence; Thiazoles; Vancomycin	2011
Antimicrobial activities of fidaxomicin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Feces; Fidaxomicin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Recurrence; Vancomycin	2012
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Creatine; Fever; Fidaxomicin; Humans; Leukocyte Count; Leukocytosis; Odds Ratio; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; ROC Curve; Severity of Illness Index; Time Factors; Treatment Failure; Vancomycin	2012
Fidaxomicin inhibits spore production in Clostridium difficile. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Load; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Gene Expression Regulation, Bacterial; Genes, Bacterial; Metronidazole; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Spores, Bacterial; Vancomycin	2012
Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:12 Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Cecum; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Feces; Glycopeptides; Humans; Lipoglycopeptides; Spores, Bacterial; Vancomycin	2012
Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:1 Topics: Aged; Anti-Bacterial Agents; Bacteriocins; Clostridioides difficile; Clostridium Infections; Drug Evaluation, Preclinical; Feces; Gastrointestinal Tract; Humans; Microbial Sensitivity Tests; Vancomycin	2013
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection. Infection, 2013, Volume: 41, Issue:2 Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin	2013
C-reactive protein is a useful predictor of metronidazole treatment failure in mild-to-moderate Clostridium difficile infection. European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Biomarkers; C-Reactive Protein; Clostridioides difficile; Clostridium Infections; Creatinine; Drug Substitution; Female; Humans; Leukocyte Count; Logistic Models; Male; Metronidazole; Middle Aged; Odds Ratio; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Failure; Vancomycin	2013
Does Candida species overgrowth protect against Clostridium difficile infection? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:3 Topics: Aminoglycosides; Candida; Clostridioides difficile; Clostridium Infections; Enterococcus; Female; Humans; Male; Vancomycin	2013
Rifaximin in the treatment of recurrent Clostridium difficile infection. Alimentary pharmacology & therapeutics, 2013, Volume: 37, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Young Adult	2013
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin	2013
Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment. BMC infectious diseases, 2012, Dec-10, Volume: 12 Topics: Animals; Anti-Bacterial Agents; Body Weight; Clostridioides difficile; Clostridium Infections; Diarrhea; Disease Models, Animal; Gene Deletion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2A; Secondary Prevention; Survival Analysis; Vancomycin	2012
Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship. Pharmacotherapy, 2012, Volume: 32, Issue:8 Topics: Academic Medical Centers; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Female; Hospitals; Humans; Length of Stay; Male; Middle Aged; Patient Readmission; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United States; Vancomycin	2012
Antimicrobial susceptibilities of Clostridium difficile isolated in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:2 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Japan; Metronidazole; Microbial Sensitivity Tests; Vancomycin	2013
Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment. The Journal of infectious diseases, 2013, May-15, Volume: 207, Issue:10 Topics: Animals; Apoptosis; Bacterial Proteins; Bacterial Toxins; Cell Line; Cell Proliferation; Clostridioides difficile; Clostridium Infections; Dipeptides; Disease Models, Animal; Enterocytes; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Necrosis; Rats; Vancomycin	2013
Late bacterial keratitis after implantation of intrastromal corneal ring segments. Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:2 Topics: Adult; Clostridium Infections; Clostridium perfringens; Cornea; Corneal Stroma; Device Removal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Gentamicins; Humans; Keratitis; Prostheses and Implants; Prosthesis Implantation; Rifamycins; Staphylococcal Infections; Staphylococcus epidermidis; Ticarcillin; Vancomycin	2003
Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile. Infection control and hospital epidemiology, 2004, Volume: 25, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child, Preschool; Clostridioides difficile; Clostridium Infections; Female; Hospitals, Teaching; Humans; Male; Middle Aged; Vancomycin; Vancomycin Resistance; Virginia	2004
Nosocomial infections: what needs to be done? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Aug-31, Volume: 171, Issue:5 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Outbreaks; Humans; Vancomycin	2004
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Aug-31, Volume: 171, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chi-Square Distribution; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Progression; Female; Humans; Incidence; Logistic Models; Male; Metronidazole; Middle Aged; Quebec; Retrospective Studies; Severity of Illness Index; Vancomycin	2004
Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report. BMC gastroenterology, 2005, Jan-24, Volume: 5 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Male; Metronidazole; Prednisone; Steroids; Vancomycin	2005
Treating C. difficile. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005, Feb-15, Volume: 172, Issue:4 Topics: Anion Exchange Resins; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Interactions; Drug Therapy, Combination; Metronidazole; Vancomycin	2005
Possible patient overlap in studies. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2007, Mar-13, Volume: 176, Issue:6 Topics: Clostridioides difficile; Clostridium Infections; Female; Follow-Up Studies; Humans; Incidence; Male; Proton Pump Inhibitors; Proton Pumps; Retrospective Studies; Risk Assessment; United Kingdom; Vancomycin	2007
Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-15, Volume: 45, Issue:12 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin	2007
Vancomycin therapy for severe Clostridium difficile-associated diarrhea. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-15, Volume: 45, Issue:12 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin	2007
Clostridium difficile-associated disease treatment response depends on definition of cure. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-15, Volume: 45, Issue:12 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin	2007
Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease. Journal of hospital medicine, 2008, Volume: 3, Issue:2 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Female; Hospitalists; Humans; Male; Metronidazole; Practice Patterns, Physicians'; Retrospective Studies; Secondary Prevention; Vancomycin	2008
Cefotaxime-associated diarrhea and Clostridium difficile. The Japanese journal of antibiotics, 1984, Volume: 37, Issue:4 Topics: Arthritis, Rheumatoid; Cefotaxime; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Middle Aged; Prednisolone; Pulmonary Fibrosis; Vancomycin	1984
Cost of vancomycin. Lancet (London, England), 1983, Nov-26, Volume: 2, Issue:8361 Topics: Clostridium Infections; Costs and Cost Analysis; Diarrhea; Humans; Vancomycin	1983
Metronidazole or vancomycin for Clostridium difficile associated diarrhoea. Lancet (London, England), 1983, Dec-17, Volume: 2, Issue:8364 Topics: Clostridium Infections; Diarrhea; Humans; Metronidazole; Vancomycin	1983
Ampicillin-induced enterocolitis: implication of toxigenic Clostridium perfringens type C. The Journal of pediatrics, 1980, Volume: 97, Issue:4 Topics: Ampicillin; Bacterial Toxins; Child; Clostridium Infections; Clostridium perfringens; Enterocolitis, Pseudomembranous; Humans; Male; Vancomycin	1980
Pseudomembranous colitis after topical application of clindamycin. Archives of dermatology, 1981, Volume: 117, Issue:3 Topics: Acne Vulgaris; Administration, Topical; Adult; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin	1981
Acute oligoarthritis associated with Clostridium difficile pseudomembranous colitis. Archives of internal medicine, 1984, Volume: 144, Issue:3 Topics: Adult; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; HLA Antigens; HLA-B27 Antigen; Humans; Male; Middle Aged; Osteoarthritis; Vancomycin	1984
[Clostridium difficile]. Zeitschrift fur arztliche Fortbildung, 1983, Volume: 77, Issue:24 Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Toxins, Biological; Vancomycin	1983
Pseudomembranous colitis with recurring diarrhoea and prolonged persistence of Clostridium difficile in a 10-year-old girl. Acta paediatrica Scandinavica, 1984, Volume: 73, Issue:1 Topics: Amoxicillin; Carrier State; Child; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Recurrence; Vancomycin	1984
Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis. Annals of internal medicine, 1984, Volume: 100, Issue:4 Topics: Anuria; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Kidney; Male; Middle Aged; Vancomycin	1984
Clostridium difficile colitis associated with the use of antineoplastic agents. European journal of clinical microbiology, 1984, Volume: 3, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Clostridium; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Male; Methotrexate; Middle Aged; Vancomycin	1984
Pseudomembranous colitis due to oxacillin therapy. Southern medical journal, 1984, Volume: 77, Issue:4 Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Middle Aged; Oxacillin; Vancomycin	1984
Absorption of vancomycin. Annals of internal medicine, 1984, Volume: 101, Issue:1 Topics: Aged; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Intestinal Absorption; Male; Middle Aged; Vancomycin	1984
Fatal pseudomembranous colitis despite eradication of Clostridium difficile. British medical journal (Clinical research ed.), 1981, Jan-10, Volume: 282, Issue:6258 Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin	1981
Antibiotic-associated colitis--the continuing saga. British medical journal (Clinical research ed.), 1981, Jun-13, Volume: 282, Issue:6280 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Vancomycin	1981
Antibiotic-associated pseudomembranous colitis. Hospital practice (Office ed.), 1981, Volume: 16, Issue:12 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Guinea Pigs; Humans; Intestines; Staphylococcal Infections; Vancomycin	1981
Vancomycin: a reappraisal. British medical journal (Clinical research ed.), 1982, May-22, Volume: 284, Issue:6328 Topics: Clostridium Infections; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterocolitis, Pseudomembranous; Humans; Staphylococcal Infections; Streptococcal Infections; Vancomycin	1982
Spontaneous persistent pseudomembranous colitis related to Clostridium difficile in ischaemic bowel disease. British medical journal (Clinical research ed.), 1982, May-29, Volume: 284, Issue:6329 Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Ischemia; Vancomycin	1982
Chronic diarrhea associated with Clostridium difficile in children. American journal of diseases of children (1960), 1983, Volume: 137, Issue:3 Topics: Bacterial Toxins; Child; Child, Preschool; Clostridium; Clostridium Infections; Diarrhea; Feces; Humans; Immunoassay; Infant; Vancomycin	1983
Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. Gut, 1983, Volume: 24, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clostridium; Clostridium Infections; Colitis; Cytotoxins; Feces; Female; Humans; Male; Middle Aged; Vancomycin	1983
Clostridium difficile toxin associated with chronic diarrhea and failure to gain weight. Clinical pediatrics, 1983, Volume: 22, Issue:6 Topics: Body Weight; Chronic Disease; Clostridium Infections; Diarrhea, Infantile; Humans; Infant; Male; Vancomycin	1983
Absorption of oral vancomycin - possible associated toxicity. The International journal of pediatric nephrology, 1983, Volume: 4, Issue:1 Topics: Administration, Oral; Adolescent; Brain Diseases; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Fever; Humans; Vancomycin	1983
An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy? Pediatrics, 1983, Volume: 71, Issue:6 Topics: Clostridium Infections; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Vancomycin	1983
Antibiotic-associated diarrhoea and pseudomembranous colitis caused by Clostridium difficile. A review of 40 cases. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1983, Jun-11, Volume: 63, Issue:24 Topics: Adult; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin	1983
Bacitracin therapy in antibiotic-associated pseudomembranous colitis. Digestive diseases and sciences, 1980, Volume: 25, Issue:10 Topics: Adult; Ampicillin; Bacitracin; Cephalosporins; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Male; Penicillin Resistance; Urinary Tract Infections; Vancomycin	1980
Clostridium difficile colitis associated with cancer chemotherapy. Archives of internal medicine, 1982, Volume: 142, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bone Neoplasms; Clostridium Infections; Colitis; Colonic Neoplasms; Diarrhea; Humans; Humerus; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Vancomycin	1982
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology, 1980, Volume: 78, Issue:3 Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Recurrence; Vancomycin	1980
Treatment of recurrent antibiotic-associated pseudomembranous colitis. The American journal of gastroenterology, 1982, Volume: 77, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin	1982
Antimicrobial susceptibility of Clostridium difficile from different sources. Microbiology and immunology, 1982, Volume: 26, Issue:1 Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clostridium; Clostridium Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Rifampin; Vancomycin	1982
Clostridium difficile: epidemiology and clinical features. Canadian journal of surgery. Journal canadien de chirurgie, 1982, Volume: 25, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Carrier State; Clostridium; Clostridium Infections; Diarrhea; Feces; Female; Humans; Male; Middle Aged; Nova Scotia; Vancomycin	1982
Diarrhea we can treat: antibiotic-associated colitis. Comprehensive therapy, 1982, Volume: 8, Issue:8 Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Vancomycin	1982
Clostridium difficile: the epidemiology and prevention of hospital-acquired infection. Infection, 1982, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Equipment and Supplies, Hospital; Feces; Humans; Vancomycin	1982
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis. Infection, 1982, Volume: 10, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Child; Clostridium; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Feces; Humans; Middle Aged; Vancomycin	1982
Clostridium difficile and inflammatory bowel disease. Gastroenterology, 1981, Volume: 80, Issue:4 Topics: Clostridium; Clostridium Infections; Colitis, Ulcerative; Crohn Disease; Cytotoxins; Humans; Inflammation; Intestinal Diseases; Vancomycin	1981
A second relapse of Clostridium difficile colitis. The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:2 Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin	1981
Studies on the epidemiology of colitis due to Clostridium difficile in hamsters. The Journal of infectious diseases, 1981, Volume: 143, Issue:1 Topics: Animals; Clostridium; Clostridium Infections; Colitis; Cricetinae; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Mesocricetus; Vancomycin	1981
Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy. Archives of internal medicine, 1981, Volume: 141, Issue:5 Topics: Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Recurrence; Vancomycin	1981
Antimicrobial agent-associated colitis and diarrhea. The Western journal of medicine, 1980, Volume: 133, Issue:2 Topics: Animals; Anti-Bacterial Agents; Clostridium Infections; Colitis; Cricetinae; Diarrhea; Humans; Infant; Infant, Newborn; Vancomycin	1980
Antibiotic-associated pseudomembranous colitis in children. Pediatrics, 1981, Volume: 67, Issue:3 Topics: Administration, Oral; Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Infant; Male; Penicillin G; Vancomycin	1981
Antimicrobial agent-associated colitis and diarrhea. Comprehensive therapy, 1981, Volume: 7, Issue:8 Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Diarrhea; Humans; Vancomycin	1981
Antibiotic-associated colitis--an abating enigma. Journal of clinical gastroenterology, 1981, Volume: 3, Issue:3 Topics: Anti-Bacterial Agents; Bacitracin; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Lincomycin; Metronidazole; Vancomycin	1981
Nonantibiotic-associated enterocolitis caused by Clostridium difficile in an infant. The Journal of pediatrics, 1981, Volume: 99, Issue:5 Topics: Biopsy; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Jejunum; Vancomycin	1981
Treatment of Clostridium difficile colitis and diarrhea with vancomycin. The American journal of medicine, 1981, Volume: 71, Issue:5 Topics: Adolescent; Adult; Aged; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Infant, Newborn; Male; Middle Aged; Recurrence; Vancomycin	1981
Clostridium difficile in gnotobiotic mice. Infection and immunity, 1980, Volume: 28, Issue:1 Topics: Animals; Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Cytotoxins; Germ-Free Life; Intestines; Male; Mice; Spores, Bacterial; Vancomycin	1980
Treatment of antibiotic-associated Clostridium difficile diarrhea with oral vancomycin. The Journal of pediatrics, 1980, Volume: 97, Issue:1 Topics: Anti-Bacterial Agents; Child; Clostridium Infections; Diarrhea; Diarrhea, Infantile; Female; Humans; Infant, Newborn; Male; Vancomycin	1980
Non-antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. Annals of internal medicine, 1980, Volume: 92, Issue:6 Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin	1980
Relapse of antibiotic-associated colitis after vancomycin therapy. The Medical journal of Australia, 1980, Apr-05, Volume: 1, Issue:7 Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin	1980
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae. Gastroenterology, 1980, Volume: 79, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cholestyramine Resin; Clostridium Infections; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Rabbits; Vancomycin	1980
Antibiotic-induced colitis. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, Jan-26, Volume: 57, Issue:4 Topics: Animals; Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Vancomycin	1980
Oxacillin-induced pseudomembranous colitis. The American journal of gastroenterology, 1980, Volume: 73, Issue:5 Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Oxacillin; Staphylococcal Infections; Vancomycin	1980
Vancomycin therapy for Clostridium difficile. The Medical journal of Australia, 1980, Jul-26, Volume: 2, Issue:2 Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Recurrence; Vancomycin	1980
Vancomycin therapy Clostridium difficile. The Medical journal of Australia, 1980, Jul-26, Volume: 2, Issue:2 Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin	1980
Relapse of Clostridium colitis after vancomycin therapy. The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:4 Topics: Adult; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin	1980
Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis. The American journal of clinical nutrition, 1980, Volume: 33, Issue:11 Suppl Topics: Animals; Anti-Bacterial Agents; Cecal Diseases; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Feces; Humans; Inflammation; Intestines; Male; Patient Isolation; Vancomycin	1980
Treatment of pseudomembranous colitis with oral metronidazole after relapse following vancomycin. The American journal of gastroenterology, 1980, Volume: 74, Issue:4 Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Vancomycin	1980
[Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin]. Gastroenterologie clinique et biologique, 1995, Volume: 19, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ascitic Fluid; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Norfloxacin; Vancomycin	1995
Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994. Acta clinica Belgica, 1995, Volume: 50, Issue:2 Topics: Clostridioides difficile; Clostridium Infections; Colitis; Humans; Metronidazole; Vancomycin	1995
Management and control of a large outbreak of diarrhoea due to Clostridium difficile. The Journal of hospital infection, 1994, Volume: 27, Issue:1 Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; England; Enterotoxins; Hospitals, General; Humans; Infection Control; Metronidazole; Middle Aged; Recurrence; Vancomycin	1994
Use of vancomycin hydrochloride for treatment of Clostridium difficile enteritis in Syrian hamsters. Laboratory animal science, 1994, Volume: 44, Issue:1 Topics: Animals; Cecum; Clostridioides difficile; Clostridium Infections; Cricetinae; Enteritis; Female; Insecticides; Male; Mesocricetus; Quinazolines; Rodent Diseases; Vancomycin	1994
Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antidiarrheals; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Loperamide; Macrolides; Male; Metronidazole; Middle Aged; Retrospective Studies; Time Factors; Vancomycin	1995
Managing C. difficile-associated diarrhea. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Jul-01, Volume: 55, Issue:13 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Microbial; Humans; Metronidazole; United States; Vancomycin	1998
ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Jul-01, Volume: 55, Issue:13 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Microbial; Humans; Metronidazole; Vancomycin	1998
Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins. Journal of clinical microbiology, 1999, Volume: 37, Issue:11 Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporin Resistance; Cephalosporins; Clostridium; Clostridium Infections; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Vancomycin	1999
Liver abscess caused by Clostridium difficile. Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:1 Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drainage; Female; Humans; Liver Abscess; Metronidazole; Recurrence; Treatment Failure; Vancomycin	2001
Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case. Diseases of the colon and rectum, 2001, Volume: 44, Issue:12 Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diverticulum, Colon; Enema; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Vancomycin	2001
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:1 Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin	2002
Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation. Applied and environmental microbiology, 1979, Volume: 38, Issue:4 Topics: Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Colitis; Culture Media; Feces; Humans; Hydrogen-Ion Concentration; Penicillins; Temperature; Vancomycin	1979
Relapse of pseudomembranous colitis after vancomycin therapy. Lancet (London, England), 1979, Nov-17, Volume: 2, Issue:8151 Topics: Administration, Oral; Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin	1979
Therapy of antibiotic-associated pseudomembranous colitis. Journal of clinical gastroenterology, 1979, Volume: 1, Issue:1 Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Colon; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Retrospective Studies; Vancomycin	1979
[A case of antibiotic-associated diarrhea caused by Clostridium difficile and treated with vancomycin]. Lakartidningen, 1979, May-02, Volume: 76, Issue:18 Topics: Aged; Clostridium; Clostridium Infections; Diarrhea; Female; Humans; Lincomycin; Toxins, Biological; Vancomycin	1979
Relapse of pseudomembranous colitis after vancomycin therapy. The New England journal of medicine, 1979, Aug-23, Volume: 301, Issue:8 Topics: Administration, Oral; Adult; Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Recurrence; Time Factors; Vancomycin	1979
Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea. Gut, 1979, Volume: 20, Issue:6 Topics: Animals; Cecum; Clindamycin; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Enterocolitis, Pseudomembranous; Intestinal Mucosa; Mesocricetus; Microscopy, Electron; Vancomycin	1979
Oral metronidazole in Clostridium difficile colitis. British medical journal, 1979, Aug-04, Volume: 2, Issue:6185 Topics: Clostridium Infections; Colitis; Humans; Metronidazole; Vancomycin	1979
Antibiotic-associated colitis--a bacterial disease. British medical journal, 1979, Aug-11, Volume: 2, Issue:6186 Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Humans; Vancomycin	1979
Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin. Canadian Medical Association journal, 1978, Nov-04, Volume: 119, Issue:9 Topics: Aged; Animals; Clostridium; Clostridium Infections; Cricetinae; Culture Techniques; Diabetes Complications; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Leg Ulcer; Lincomycin; Vancomycin	1978
Clindamycin-induced colitis. The American journal of clinical nutrition, 1979, Volume: 32, Issue:1 Topics: Animals; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Mesocricetus; Metronidazole; Vancomycin	1979
Clostridium difficile infection--a poor prognostic sign in uremic patients? Clinical nephrology, 1992, Volume: 38, Issue:1 Topics: Clostridioides difficile; Clostridium Infections; Disease Outbreaks; Female; Follow-Up Studies; Hospital Units; Humans; Male; Middle Aged; Prognosis; Regression Analysis; Risk Factors; Sweden; Uremia; Vancomycin	1992
Diarrhea in hospitalized patients. American journal of physical medicine & rehabilitation, 1992, Volume: 71, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cytotoxins; Diarrhea; Feces; Humans; Inpatients; Metronidazole; Middle Aged; Rehabilitation Centers; Vancomycin	1992
Empyema caused by Clostridium sordellii, a rare form of pleuropulmonary disease. The Journal of infection, 1991, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Empyema; Female; Humans; Lactams; Metronidazole; Sputum; Vancomycin	1991
Aminoglycosides and C. difficile colitis. The New England journal of medicine, 1990, Feb-01, Volume: 322, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Colitis; Humans; Vancomycin	1990
Multiple relapses of Clostridium difficile-associated diarrhea responding to an extended course of cholestyramine. The Pediatric infectious disease journal, 1989, Volume: 8, Issue:3 Topics: Bacterial Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Diarrhea, Infantile; Drug Therapy, Combination; Enterotoxins; Female; Humans; Infant; Male; Recurrence; Vancomycin	1989
Clostridium difficile infection in health-care workers. Lancet (London, England), 1989, Oct-07, Volume: 2, Issue:8667 Topics: Administration, Oral; Adult; Clostridium Infections; Cross Infection; Humans; Male; Nurses; Vancomycin	1989
Comparison of two oral formulations of vancomycin for treatment of diarrhoea associated with Clostridium difficile. The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clostridium; Clostridium Infections; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Vancomycin	1989
A hospital outbreak of Clostridium difficile? The Journal of hospital infection, 1985, Volume: 6, Issue:3 Topics: Age Factors; Aged; Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cross Infection; Disease Outbreaks; Environmental Microbiology; Equipment Contamination; Feces; Female; Humans; Male; Patient Isolation; Retrospective Studies; Vancomycin	1985
Prevention of Clostridium difficile outbreaks in hospitals. Lancet (London, England), 1986, Aug-09, Volume: 2, Issue:8502 Topics: Clostridium; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Vancomycin	1986
Clostridium difficile toxin in chronic idiopathic colitis. The New Zealand medical journal, 1986, Aug-27, Volume: 99, Issue:808 Topics: Adult; Bacterial Proteins; Bacterial Toxins; Chronic Disease; Clostridium; Clostridium Infections; Colitis; Colitis, Ulcerative; Crohn Disease; Diarrhea; Female; Humans; Male; Sulfasalazine; Vancomycin	1986
Phenelfamycins, a novel complex of elfamycin-type antibiotics. III. Activity in vitro and in a hamster colitis model. The Journal of antibiotics, 1989, Volume: 42, Issue:1 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; Clostridium Infections; Cricetinae; Enterocolitis; Male; Mesocricetus; Vancomycin	1989
Therapy of Clostridium difficile in pseudomembranous and antibiotic-associated colitis. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Anti-Bacterial Agents; Cholestyramine Resin; Clostridium Infections; Colitis; Glycopeptides; Humans; Metronidazole; Teicoplanin; Vancomycin	1987
Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. Journal of clinical gastroenterology, 1987, Volume: 9, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Clostridium; Clostridium Infections; Colitis; Diarrhea; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Vancomycin	1987
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1987, Volume: 9, Issue:5 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridium Infections; Colitis; Drug Evaluation; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Vancomycin	1987
The effects of acute clostridium difficile diarrhea on fecal nitrogen content in adult hospitalized patients. Journal of the American College of Nutrition, 1987, Volume: 6, Issue:3 Topics: Adult; Aged; Body Weight; Clostridium Infections; Diarrhea; Energy Intake; Feces; Female; Humans; Male; Middle Aged; Nitrogen; Nutritional Status; Serum Albumin; Vancomycin	1987
A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile. Diseases of the colon and rectum, 1986, Volume: 29, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Child; Child, Preschool; Clostridium Infections; Colon; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Motility; Humans; Infant; Male; Middle Aged; Risk; Vancomycin	1986
[Therapeutic progress: vancomycin]. Boletin de la Asociacion Medica de Puerto Rico, 1985, Volume: 77, Issue:7 Topics: Clostridium Infections; Drug Hypersensitivity; Humans; Kidney Diseases; Staphylococcal Infections; Streptococcal Infections; Vancomycin	1985
[Enterocolitis caused by Clostridium difficile. Analysis of 15 cases in adults]. Deutsche medizinische Wochenschrift (1946), 1986, Jan-10, Volume: 111, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium; Clostridium Infections; Enterocolitis; Feces; Female; Humans; Male; Middle Aged; Risk; Vancomycin	1986
Pseudomembranous colitis following prophylactic antibiotic use in primary cesarean section. American journal of obstetrics and gynecology, 1985, Jan-01, Volume: 151, Issue:1 Topics: Adult; Cesarean Section; Clostridium; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Postoperative Complications; Pregnancy; Vancomycin	1985
Clostridium difficile colitis following head and neck surgery. Report of cases. Archives of otolaryngology (Chicago, Ill. : 1960), 1985, Volume: 111, Issue:8 Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Head and Neck Neoplasms; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Premedication; Vancomycin	1985
Antimicrobial considerations in anaerobic infections. The Medical clinics of North America, 1974, Volume: 58, Issue:3 Topics: Actinomycetales Infections; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium Infections; Erythromycin; Fusobacterium; Humans; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Oxygen; Penicillins; Rifampin; Streptococcal Infections; Tetracycline; Treponemal Infections; Vancomycin; Veillonella	1974